WO2007129674A1 - Fermented product composition, cosmetic composition and method of producing the same - Google Patents

Fermented product composition, cosmetic composition and method of producing the same Download PDF

Info

Publication number
WO2007129674A1
WO2007129674A1 PCT/JP2007/059398 JP2007059398W WO2007129674A1 WO 2007129674 A1 WO2007129674 A1 WO 2007129674A1 JP 2007059398 W JP2007059398 W JP 2007059398W WO 2007129674 A1 WO2007129674 A1 WO 2007129674A1
Authority
WO
WIPO (PCT)
Prior art keywords
fermented product
peptide
composition
fermented
vitamin
Prior art date
Application number
PCT/JP2007/059398
Other languages
French (fr)
Japanese (ja)
Inventor
Toshitaka Okada
Kenji Fujisawa
Hiroko Takahashi
Original Assignee
Toyo Hakko Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Hakko Co., Ltd. filed Critical Toyo Hakko Co., Ltd.
Priority to CN2007800157909A priority Critical patent/CN101431980B/en
Priority to JP2008514485A priority patent/JP4945556B2/en
Priority to KR1020087026036A priority patent/KR101397976B1/en
Publication of WO2007129674A1 publication Critical patent/WO2007129674A1/en
Priority to HK09108313.4A priority patent/HK1130182A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Definitions

  • the present invention relates to a fermented product composition, a cosmetic composition, and a method for producing them. More specifically, the present invention relates to a fermented product composition excellent in collagen synthesizing action and the like with high safety. The present invention also relates to a cosmetic composition comprising the fermented product composition. Furthermore, this invention relates to the manufacturing method of the said fermented material composition and cosmetics composition.
  • Patent Document 1 discloses a cosmetic composition containing a fermented rice cake and a cosmetic using the same. In Patent Document 1, it is described that this cosmetic product is excellent in moisture retention and is comfortable and less irritating when applied to the skin.
  • Patent Document 2 discloses a method for producing a raw material for external preparation for skin obtained by fermenting rice bran and soybean peptide with Bacillus subtilis and then purifying it. In Patent Document 2, the raw material for external preparation for skin is described as having the ability S to enhance the activity of the skin, which is highly safe.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2004-262829
  • Patent Document 2 JP-A-8-104647
  • cosmetics such as external preparations for skin are many.
  • cosmetics such as an external preparation for skin containing this fermented product can suppress wrinkles, blemishes, sagging and the like, and can prevent dullness, redness and rough skin.
  • cosmetics such as external preparations for skin containing this fermented product can provide effects such as wound healing and improvement of symptoms such as burns.
  • An object of the present invention is to provide a fermented product composition excellent in collagen synthesizing action and the like with high safety.
  • the present invention also provides a cosmetic composition comprising the fermented composition. The purpose is to do.
  • an object of this invention is to provide the manufacturing method of the said fermented material composition and cosmetics composition.
  • the present invention is as follows.
  • a fermented product composition comprising a fermented product obtained by fermenting rice bran strength and a bean-derived peptide with Bacillus subtilis, and at least one of peptides and vitamins A
  • a cosmetic composition comprising the fermented product composition described in [1] above.
  • a fermented product composition comprising a mixing step of mixing fermented material obtained by fermenting rice bran and bean-derived peptides with Bacillus subtilis and at least one of peptide and vitamin A Manufacturing method.
  • a method for producing a cosmetic composition comprising:
  • the fermented product composition of the present invention uses a natural product as a raw material. Therefore, the fermented product composition of the present invention has high safety and excellent collagen synthesis action and cell growth action.
  • the peptide is at least one of a peptide obtained by hydrolyzing soy protein and synolephifiproin, a fermented product composition that is more easily available and has sufficient collagen synthesis properties, etc. it can.
  • the cosmetic composition of the present invention has an excellent collagen synthesis action and cell proliferation action by having the above-described configuration.
  • the fermented product composition and the cosmetic composition can be produced by fermentation using Bacillus subtilis which is easily available. Therefore, it has the above-mentioned excellent action
  • the fermented product composition of the present invention can be produced safely and easily with a small production facility.
  • the fermented product composition of the present invention contains a fermented product obtained by fermenting rice bran and a bean-derived peptide with Bacillus subtilis, and at least one of a peptide and vitamin A.
  • Examples of the "rice bran” include rice bran, defatted rice bran, rice germ, and defatted rice germ. These may be used alone or in combination of two or more. As the rice bran, various types of rice bran can be used without being limited to commercially available rice bran.
  • bean-derived peptide is not particularly limited in its specific type and structure as long as it is a peptide contained in beans or a peptide derived from proteins contained in beans.
  • bean-derived peptide various kinds of bean-derived peptides can be used without being limited to commercially available bean-derived peptides.
  • the bean-derived peptide include soybean peptide, red bean peptide, endo peptide and broad bean peptide.
  • soybean peptide soybean peptide is preferable.
  • the legume-derived peptides may be used alone or in combination of two or more.
  • the method for obtaining the bean-derived peptide there is no particular limitation on the method for obtaining the bean-derived peptide.
  • the above-mentioned peptides derived from beans are made of beans (for example, one or more of soybeans, red beans, endu and broad beans) as solvents (water, hot water, organic solvents such as alcohol (ethanol etc.) or water-one organic solvents. It can be obtained by extraction with a mixed solvent. In this process, fractionation and purification can be performed as necessary.
  • the obtained legume-derived peptide or legume protein can be further fragmented by subjecting it to a hydrolysis treatment with protease, acid or alkali.
  • the above-mentioned bean-derived peptide is an artificially synthesized peptide obtained by chemically peptide-binding amino acids or by a known genetic engineering technique.
  • the bean-derived peptide can be made into a solid (eg, a powdery product or a granular product) solidified by drying or the like after the above extraction.
  • the said extract itself can be used as said bean-derived peptide. That is, in the present invention, an extract containing a bean-derived peptide (bean extract, particularly soybean extract) can be used as the bean-derived peptide.
  • beans for example, one or more of soybeans, red beans, endu, and broad beans
  • solvents water, hot water, alcohol (ethanol, etc.) organic solvents.
  • an extract obtained by extraction with a water-organic solvent mixed solvent can be used.
  • an extract (soybean extract) containing soybean peptide is particularly preferably used.
  • the extraction method and extraction conditions for obtaining an extract containing the bean-derived peptide there are no particular limitations on the extraction method and extraction conditions for obtaining an extract containing the bean-derived peptide.
  • beans that are extraction raw materials may be unground or pulverized.
  • pretreatment such as impurity removal may be performed.
  • the extraction solvent include water or hot water, alcohols such as methanol and ethanol, esters such as ethyl acetate, organic solvents such as n-xane, mixed solvents of these organic solvents and water or hot water, and the like. Can be used.
  • water or hot water, alcohol (such as methanol and ethanol), and a mixed solvent of water or hot water and alcohol are preferable.
  • the temperature of the hot water is usually 40 to 100 ° C, preferably 50 80 ° C, more preferably 50 70 ° C.
  • the pH of the extraction solvent during extraction is usually 37, preferably 46, and more preferably 45. It is preferable to adjust the pH within the above range since the stability of various components contained in the extraction raw material can be maintained.
  • the extraction temperature is not particularly limited, but normal temperature or heat extraction is preferable.
  • the heating temperature is usually 40 to 100 ° C, preferably 5080 ° C, more preferably 5070C. It is preferable because the extraction can be performed efficiently by setting the heating temperature within the effective range.
  • the ratio between the above-mentioned rice force and the above-mentioned bean-derived peptide there is no particular limitation on the ratio between the above-mentioned rice force and the above-mentioned bean-derived peptide.
  • the ratio of the rice bran is 120 parts by mass, preferably 520 parts by mass, more preferably 8 to 18 parts by mass.
  • the above rice bran is in the above range If so, a fermented product having a sufficient collagen synthesis action and the like can be obtained.
  • Bacillus subtilis is a typical kind of aerobic spore-forming bacteria.
  • the type of Bacillus subtilis is not particularly limited as long as safety is guaranteed.
  • Bacillus subtilis for example, Bacillus natto can be used.
  • Bacillus subtilis Bacillus natto that is easily available and inexpensive is preferable.
  • Bacillus subtilis commercially available general Bacillus subtilis can be used.
  • the Bacillus subtilis may be produced naturally or by a chemical substance such as nitrosoguanidine, X-rays, ultraviolet rays, etc. Mutants with altered chemistry can also be used.
  • the "fermented product” is obtained by fermenting the rice bran and the bean-derived peptide with Bacillus subtilis.
  • the fermented product is usually obtained by ingesting Bacillus subtilis into a medium containing the rice bran and the beans-derived peptide and fermenting and culturing under appropriate conditions.
  • the fermentation culture conditions for obtaining the above “fermented product” are not particularly limited. Fermentation culture is usually performed by aeration and agitation.
  • the medium is not particularly limited as long as the Bacillus subtilis can grow.
  • the medium is usually a liquid medium, but it cannot be a solid medium.
  • the pH of the medium (especially during fermentation) is usually 5.5 to 8.5, preferably 6.0 to 8.0, and more preferably 6.5 to 7.5.
  • the culture temperature is not particularly limited as long as fermentation is performed.
  • the culture temperature is usually 15 to 50 ° C, preferably 20 to 45 ° C, more preferably 30 to 45 ° C, and more preferably 35 to 43 ° C.
  • various nutrients such as sugar and acid and alkali for pH adjustment may be added to the medium.
  • the fermentation may be mixed fermentation or continuous fermentation.
  • the form of the fermented product is not particularly limited.
  • the fermented product may be a fermented liquid obtained by fermentation culture or a liquid obtained by filtering the fermented liquid.
  • the fermented product is sterilized or pH-adjusted as necessary with respect to the fermented liquid, or after-treatment such as deodorization / decolorization using an ion exchange resin, an activated charcoal column or a dialysis membrane. Fermented broth may be used.
  • the fermented product may be a concentrated solution or a paste-like product obtained by concentrating the fermented solution.
  • the fermented product may be a solid product or a powdered product obtained by removing the solvent from the fermented solution by a known method such as freeze drying.
  • the fermented product is a solution or dispersion obtained by adding the fermented liquid or the solid and powdered materials to water or an organic solvent such as ethanol, propylene glycol and 1,3-butylene glycol, or a mixed solvent thereof. You can also use it as a liquid.
  • the "peptide” is a polypeptide in which amino acids are bound by peptide bonds.
  • the amino acid may be a force D-amino acid, which is usually an L-amino acid, or a mixture of both. That is, the amino acids constituting the peptide are L-amino acids, D-amino acids, and a mixture of both, or may be shifted.
  • the type, origin, and structure of the peptide are not particularly limited.
  • the peptide may be a plant-derived peptide contained in a plant or an animal-derived peptide contained in an animal.
  • the structure of the peptide may include not only a linear structure but also a disulfide bond.
  • Specific examples of the peptide include, for example, peptides obtained by hydrolyzing soy protein (proteins contained in soybean) and silk peptides such as silk-five phine (the peptides contained in silk and the proteins contained in silk are hydrolyzed. Peptide obtained by degradation). By using these peptides, it is possible to obtain a fermented product composition having an excellent collagen synthesis effect and cell proliferation effect.
  • the method for obtaining the peptide is not particularly limited.
  • the above peptides can usually be obtained by hydrolyzing various proteins with protease, acid, alkali or the like.
  • the specific hydrolysis method and conditions are not particularly limited.
  • the kind of the protein is not particularly limited.
  • the protein include soy protein and silk protein contained in silk.
  • a peptide artificially synthesized by chemically bonding amino acids to each other or by a known genetic engineering technique can be used as the above peptide.
  • the number of amino acids and the molecular weight of the peptide are not particularly limited.
  • the lower limit of the number of amino acids of the peptide can be set to 2, 3, or 4, for example.
  • the upper limit of the number of amino acids of the peptide can be, for example, 100, 80, 60, or 40.
  • the lower limit of the molecular weight of the peptide can be set to 50, 100 or 200, for example.
  • the peptide molecule As the upper limit of quantity, if it is column f, it can be set to 300000, 200000, 100000, 50000 or 30000.
  • a high molecular weight peptide for example, a peptide having a molecular weight of 40,000 or more as the peptide.
  • the molecular weight of the peptide can be measured by various known methods.
  • the molecular weight of the peptide can be measured by, for example, electrophoresis using SDS-PAGE and gel filtration chromatography using HPLC and a column.
  • the amino acid number and molecular weight of the peptide can be appropriately adjusted by hydrolyzing the protein or peptide with a protease, acid, alkali, or the like.
  • the peptide is preferably (1) a peptide having a molecular weight of 200 to 200,000, (2) a peptide having an amino acid number of 4 to 40 and a molecular weight of 220 to 8000, and (3) an amino acid number force.
  • silk fiber mouth-in is more preferable.
  • a peptide obtained by hydrolyzing soy protein, having 2 to 6 amino acids and having a molecular weight of 100 to 1200 is preferable.
  • a fermented product composition having superior collagen synthesizing action, cell proliferating action, etc., compared to the case of containing only fermented product. it can.
  • the above peptides may be used alone or in combination of two or more.
  • the peptide only one of the various peptides described above may be used, or two or more may be used in combination.
  • 2 or more types of peptides from which an amino acid number and / or molecular weight differ may be included.
  • two or more kinds of peptides of different kinds such as a peptide obtained by hydrolyzing soy protein and a silk peptide such as sinoretafive mouth-in, can be used in combination.
  • vitamin A is a compound having an isoprenoid-type polyalcohol as a basic skeleton and a derivative of the compound.
  • vitamin A include, for example, Examples include vitamin Al (retinol), vitamin A2, vitamin A3, and 3,4-dihydroretinol, as well as aldehydes (retinal and the like) and carboxylic acids (retinoic acid) and the like which are oxidized.
  • the “vitamins A” include pharmaceutically acceptable salts and pharmaceutically acceptable derivatives.
  • the derivatives include carboxylic acid esters such as the above retinol. More specifically, examples of the derivative include C1-C30 esters such as retinoyl acetate and retinol palmitate.
  • the above vitamins may be used alone or in combination of two or more.
  • the vitamin A itself may be contained in combination with other substances that may be contained in the fermented product composition of the present invention.
  • the vitamin A can be contained in the fermented product composition of the present invention as an inclusion compound included in a host compound such as cyclodextrin.
  • the vitamin A can be contained in the fermented product composition of the present invention as a composition or mixture containing the vitamin A.
  • the vitamin A can be contained in the fermented product composition of the present invention as a composition containing the vitamin A such as liver oil.
  • the vitamin A can be contained in the fermented product composition of the present invention as a solution or dispersion in which the vitamin A is dissolved or dispersed.
  • the vitamin A can be dissolved in animal oil or vegetable oil, and the solution can be contained in the fermented product composition of the present invention.
  • the ratio of the fermented product to the peptide and the vitamin A is not particularly limited.
  • the ratio of the fermented product is usually 0.:!-99.9% by mass, preferably 10-80% by mass, More preferably, it is 40-60 mass%.
  • the collagen synthesis action or the like is improved by containing the fermented product, one or more of the above peptides and vitamin A.
  • the content of each of one or more of the fermented product, the peptide, and the vitamin A is not greatly different, that is, when the mass ratio of the fermented product is 40 to 60% by mass. Is preferable because the collagen synthesis action and the like are further improved.
  • the fermented product composition of the present invention can be used for various applications. Especially for this application There is no limitation.
  • the fermented product composition of the present invention can be used, for example, for cosmetics such as external preparations for skin, cosmetic materials, foods and drinks, food and drink additives, bathing agents, and the like.
  • the fermented product composition of the present invention can be blended in cosmetics, foods and drinks, and the like.
  • the blended amount of the fermented product composition of the present invention is not particularly limited.
  • the blending amount can be blended in an appropriate amount depending on the type of cosmetics.
  • the blending amount of the fermented product composition of the present invention can be 0.001 to 100% by mass, especially 0.001 to 50% by mass when the cosmetic is 100% by mass.
  • a cosmetic product having an excellent collagen synthesis action and the like can be obtained.
  • the types of cosmetics to which the fermented product composition of the present invention can be blended are not particularly limited.
  • the cosmetics include, for example, freeze-drying, packs, pack sheets, peeling, powders, lotions, white towels, solid white lipsticks, lipsticks, solid scarlet, foundation creams, emulsions, lotions, body lotions, cleansing lotions. , Face washing cream, skin care cream, hair rinse, hair liquid, eye shadow and eyebrows.
  • other ingredients such as plant sex, vitamins, vitamin-like substances, minerals, lower alcohols, polyhydric alcohols, oils and fats, surfactants are used as necessary. This can be done by adding additives, antioxidants, UV absorbers, thickeners, pigments, preservatives, and fragrances.
  • Examples of cosmetics containing the fermented product composition of the present invention include skin external preparations.
  • the fermented product composition of the present invention has an excellent collagen synthesis action and the like. Therefore, the fermented product composition of the present invention is particularly useful for cosmetics used by applying to the skin.
  • the external preparation for skin containing the fermented product composition of the present invention as an active ingredient can be prepared using the fermented product composition of the present invention and other compounding agents used for the external skin preparation.
  • Examples of other binders include liquid oil (such as squalane and jojoba oil), solid oil (such as beeswax and cetyl alcohol), various activators, and humectants (such as glycerin and 1,3-butylene alcohol). Is mentioned.
  • the dosage form of the external preparation for skin can be made into various dosage forms according to the purpose, such as lotion, cream and emulsion.
  • the blending amount of the fermented product composition of the present invention is not particularly limited.
  • the amount of the fermented product composition of the present invention is 100% by mass when the external preparation for skin is 100% by mass.
  • the content can be set to 0.001 to 100% by mass, particularly 0.001 to 50% by mass. If the content of the fermented product composition of the present invention is within the above range, it can be used as a skin external preparation having an excellent collagen synthesis action and the like.
  • the food and drink containing the fermented product composition of the present invention includes, for example, the fermented product composition of the present invention mixed with other food raw materials or a premixed food raw material mixture of the fermented product composition of the present invention. And then processed by a general method.
  • the food and drink containing the fermented product composition of the present invention is prepared by, for example, dissolving the fermented product composition of the present invention in fats and oils, ethanol, propylene glycol, glycerin or a mixture thereof, and blending it into beverages or solid foods. Can be manufactured.
  • foods and drinks containing the fermented product composition of the present invention are prepared by mixing the fermented product composition of the present invention with a binder such as gum arabic and dextrin to form a powder or granules, which are used as beverages or solid foods. It can be manufactured by blending. Foods and drinks containing the fermented product composition of the present invention can be provided as health foods and functional foods.
  • a blend containing the fermented product composition of the present invention can also be used as a cosmetic material, a bath agent, an additive for food and drink, and the like.
  • the cosmetic composition, cell-utilized skin external preparation composition and cosmetic raw material of the present invention are characterized by containing the fermented product composition of the present invention.
  • the contents already described apply to the cosmetic composition, the skin external preparation composition for cell activation, and the fermented composition contained in the cosmetic raw material of the present invention.
  • the proportion of the fermented composition in the cosmetic composition, cell-utilized skin external preparation composition, and cosmetic raw material of the present invention is not particularly limited.
  • the proportion of the fermented composition For example, the cosmetic composition of the present invention, a cell activator skin external agent composition and the entire cosmetic raw material is 100 mass 0/0, 0.001 to 100 weight 0 / 0, can be this a force s and in particular from 0.001 to 50 mass 0/0. If the proportion of the fermented product composition is within the above range, it can be made into a cosmetic composition having excellent collagen synthesizing action and the like, a cell-utilized skin external preparation composition, and a cosmetic raw material.
  • the type of the cosmetic composition of the present invention is not particularly limited.
  • the cosmetic composition For example, freeze-drying, knocking, pack sheet, peeling, white lipstick, solid white, lipstick, solid scarlet, foundation cream, emulsion, lotion, body lotion, cleansing cream, facial cream, skin care cream, hair Rinse, hair liquid, shadow and eyebrows.
  • the cosmetic composition of the present invention may contain other components (for example, plant extracts, vitamins, vitamin-like substances, mineralols, lower alcohols, polyhydric alcohols, oils and fats, interfaces, depending on the type of the cosmetic composition.
  • Activators, antioxidants, UV absorbers, thickeners, dyes, preservatives and fragrances can also be added.
  • the cosmetic composition of the present invention includes a skin external preparation.
  • the fermented product composition has an excellent collagen synthesis action and the like. Therefore, the fermented product composition is particularly useful for cosmetics that are applied to the skin.
  • the said external preparation for skin can be prepared using the said fermented composition and the other compounding agent used for an external preparation for skin.
  • Other compounding agents include, for example, liquid oil (such as squalane and jojoba oil), solid oil (such as micro- and cetyl alcohol), various activators, and humectants (such as glycerin and 1,3-butylene glycol). Is mentioned. There are no particular limitations on the dosage form of this topical skin preparation.
  • This external preparation for skin can be made into various dosage forms according to the purpose, such as lotion, cream and milky lotion.
  • the amount of the fermented product composition is not particularly limited.
  • the blending amount of the fermented product composition can be 0.001 to 100% by mass, particularly 0.001 to 50% by mass, when the external preparation for skin is 100% by mass. If the content of the fermented product composition is within the above range, it can be used as a skin external preparation having excellent collagen synthesis action and the like.
  • the cell-stimulated skin external preparation of the present invention contains the fermented product composition.
  • the fermented product composition has an excellent collagen synthesis action and the like. Therefore, the fermented product composition is particularly useful when blended in cosmetics that are applied to the skin.
  • the description of the above-mentioned skin external preparation can be applied as it is to the cell skin external preparation of the present invention.
  • the cosmetic raw material of the present invention includes, for example, freeze-drying, packs, pack sheets, peeling, powder, lotion, white lipstick, solid white lipstick, solid red lipstick, foundation tarm, emulsion, lotion, Used in body lotions, cleansing lotions, facial creams, skin care creams, hair rinses, hair liquids, eye shadows and eyebrows I can.
  • the fermented product composition, cosmetic composition, cell-utilized skin external preparation composition and cosmetic raw material production method of the present invention are fermented products obtained by fermenting rice bran strength and legume-derived peptides with Bacillus subtilis. And a mixing step of mixing at least one of peptide and vitamin A.
  • the above-mentioned "fermented product” is usually obtained by a fermentation process in which Bacillus subtilis is inoculated and fermented in a medium containing rice bran and legume-derived peptides.
  • the “medium” in the “fermentation step” may be any medium that contains rice bran and a bean-derived peptide and that allows Bacillus subtilis to grow and perform fermentation culture. There is no limitation in particular in the kind and composition of the said culture medium.
  • the medium is usually a liquid medium, but may be a solid medium.
  • the pH of the above medium (especially fermentation B temple) is usually 5 ⁇ 5 to 8 ⁇ 5, preferably ⁇ or 6 ⁇ 0 to 8 ⁇ 0, and more preferably ⁇ or 6 ⁇ 5 to 7 ⁇ 5.
  • saccharides such as gnolecose, enzymes such as protease, water such as purified water, and the like can be added to the medium.
  • the culture temperature during the fermentation is not particularly limited as long as the fermentation is performed.
  • the culture temperature is usually 15 to 50 ° C, preferably 20 to 45 ° C, more preferably 30 to 45 ° C, more preferably 35 to 43 ° C.
  • Fermentation culture is usually performed by aeration and agitation.
  • the form of the fermented product obtained by the fermentation process is not particularly limited.
  • the contents described in the fermented product composition of the present invention are applied to the fermented product.
  • the method of mixing the fermented product with at least one of the peptide and vitamin A in the "mixing step" The fermented product and the peptide can be mixed using an appropriate apparatus such as a mixer such as a homomixer depending on the form and the mass ratio of each. Further, the temperature at the time of mixing is not particularly limited, and is preferably set according to the type of fermented product and peptide. Fermented products and peptides are 5 ⁇ It can be mixed while cooling if necessary in the range of 20 ° C, and can be mixed while heating if necessary in the range of 35 to 85 ° C.
  • the production method of the present invention may further include other steps.
  • purify the said fermented material are mentioned, for example.
  • the fermented product obtained by the fermentation process may be mixed with the peptide as it is, or the fermented product may be purified and then mixed with the peptide.
  • the method for this purification treatment is not particularly limited.
  • the fermented product can be purified by pressing and filtering the fermentation broth.
  • the fermentation broth can be purified by squeezing and filtering the fermented liquor, followed by deodorization with activated charcoal and the like, decoloration treatment, and Z or sediment removal treatment, and then filtering again. .
  • the contents of the step of obtaining the cosmetic composition and the cell-applied skin external preparation composition by formulating the fermented product composition are particularly limited as long as the cosmetic composition and the cell-applied skin external preparation composition can be obtained. There is no.
  • the fermented composition, the cosmetic composition, and other ingredients constituting the cell activation skin external preparation composition are mixed and formulated into a tablet or liquid preparation, so that the cosmetic composition and the cell utilization are obtained.
  • a skin external preparation composition can be obtained.
  • the above fermented product composition can be directly formulated into a tablet or liquid preparation to make a cosmetic composition and a cell-utilized skin external preparation composition.
  • Vitamin C and silk fiber mouth-in are the same as those used in [2] above.
  • silk peptides (a) and (b) were both liquids, and were diluted with a buffer solution so that the final concentration as a solid content concentration was 1% (mass Z volume).
  • Tables 3 to 5 show the average values of collagen synthesis in Plate 1 (P1) and Plate 2 (P2). Further, assuming that each collagen synthesis amount in Experimental Examples 16, 23 and 32 was 1, the relative value of the collagen synthesis amount in other experimental examples was determined. The results are also shown in Tables 3-5. In Tables 3 to 5, “VC” means vitamin C, “SF” means silk five mouth in, and “SPJ means silk peptide”.
  • Vitamin C and silk fiber mouth-in are the same as those used in [2] above.
  • the following were used as soybean peptides (a) to (c).
  • the soybean peptides (a), (b), and (c) were all liquids, and were used after being diluted with a buffer solution so that the final concentration as a solid content concentration was 1% (mass Z volume).
  • Table 6 shows the average value of the amount of collagen synthesis in Plate 1 (P1) and Plate 2 (P2). Further, assuming that the amount of collagen synthesis in Experimental Example 37 was 1, the relative value of the amount of collagen synthesis in other Experimental Examples was determined. The results are also shown in Table 6.
  • “VC” means Vitamin C
  • “SF” means Synoletafibu Mouth Inn
  • Each of the two 96-well plate was distributed with 2000 human skin fibroblasts per well. Subsequently, the cells were cultured for 3 days in a MEM medium supplemented with 5% FBS. Thereafter, the medium was replaced with a serum-free MEM medium and further cultured for 1 day. 0.5% serum-added MEM medium
  • a sample-added medium was prepared by adding the samples of Experimental Examples 48-56. The concentration of the sample solutions of the above Experimental Examples 48 to 56 in the sample-added medium is 1% (mass Z volume, excluding the mass of the PBS). The final concentration of the component is 1/100 of the concentration in the sample solution.) Then, the serum-free MEM medium in the well was replaced with the sample-added medium, and further cultured for 4 days.
  • ⁇ 0 means vitamin 0
  • SF means silk-five mouth-in
  • SBP (a) to (c) means soybean peptides (a) to (c).
  • the average value of the cell growth rate term in Table 7 is the average value of the absorbance values.
  • PBS buffer solution
  • the fermented product composition of the present invention is excellent in safety and has a collagen synthesis action and the like.
  • the fermented product composition of the present invention can be used by blending it with various cosmetics such as external preparations for skin and various foods such as health foods and functional foods. That is, the present invention can be used in the fields of cosmetics and foods and drinks.

Abstract

A fermented product composition and a cosmetic composition comprising a fermented product, which is obtained by fermenting peptides originating in rice bran and beans by using Bacillus subtilis, and at least one member selected from peptides and vitamin A analogs. A production method comprising a mixing step wherein a fermented product, which is obtained by fermenting peptides originating in rice bran and beans by using Bacillus subtilis, is mixed with at least one member selected from peptides and vitamin A analogs.

Description

明 細 書  Specification
発酵物組成物、化粧品組成物及びそれらの製造方法  Fermented product composition, cosmetic composition and method for producing them
技術分野  Technical field
[0001] 本発明は、発酵物組成物、化粧品組成物及びそれらの製造方法に関する。更に詳 しくは、本発明は、安全性が高ぐコラーゲン合成作用等に優れた発酵物組成物に 関する。また、本発明は、該発酵物組成物を含む化粧品組成物に関する。更に、本 発明は、上記発酵物組成物及び化粧品組成物の製造方法に関する。  [0001] The present invention relates to a fermented product composition, a cosmetic composition, and a method for producing them. More specifically, the present invention relates to a fermented product composition excellent in collagen synthesizing action and the like with high safety. The present invention also relates to a cosmetic composition comprising the fermented product composition. Furthermore, this invention relates to the manufacturing method of the said fermented material composition and cosmetics composition.
背景技術  Background art
[0002] 従来より、米ぬか等を発酵させて得られる発酵物を含有する皮膚外用剤等の化粧 品等が知られている。例えば、特許文献 1には、発酵糠類を含有する化粧品組成物 及びそれを用いた化粧品が開示されている。特許文献 1において、この化粧品は、 保湿性に優れ、皮膚に塗布した際の刺激が少なぐ炎症が発生し難く快適であること が記載されている。また、特許文献 2には、米ぬかと大豆ペプチドとを枯草菌により発 酵させ、その後、精製処理して得られる皮膚外用剤原料の製造方法が開示されてい る。特許文献 2において、この皮膚外用剤原料は安全性が高ぐ皮膚の活性を高め ること力 Sできること力 S記載されてレ、る。  [0002] Conventionally, cosmetics such as external preparations for skin containing fermented products obtained by fermenting rice bran and the like are known. For example, Patent Document 1 discloses a cosmetic composition containing a fermented rice cake and a cosmetic using the same. In Patent Document 1, it is described that this cosmetic product is excellent in moisture retention and is comfortable and less irritating when applied to the skin. Patent Document 2 discloses a method for producing a raw material for external preparation for skin obtained by fermenting rice bran and soybean peptide with Bacillus subtilis and then purifying it. In Patent Document 2, the raw material for external preparation for skin is described as having the ability S to enhance the activity of the skin, which is highly safe.
[0003] 特許文献 1 :特開 2004— 262829号公報 Patent Document 1: Japanese Patent Application Laid-Open No. 2004-262829
特許文献 2:特開平 8— 104647号公報  Patent Document 2: JP-A-8-104647
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 特許文献 1及び 2記載の発酵物を皮膚外用剤等の化粧品に配合することによる効 能は多い。例えば、この発酵物を配合した皮膚外用剤等の化粧品は、しわ、しみ、た るみ等を抑えることができ、しもやけ、あかぎれ及び肌荒れ等を予防することができる 。また、この発酵物を配合した皮膚外用剤等の化粧品では、創傷治癒及び火傷等の 症状の改善等の効能が得られる。 [0004] The effects of blending the fermented products described in Patent Documents 1 and 2 into cosmetics such as external preparations for skin are many. For example, cosmetics such as an external preparation for skin containing this fermented product can suppress wrinkles, blemishes, sagging and the like, and can prevent dullness, redness and rough skin. In addition, cosmetics such as external preparations for skin containing this fermented product can provide effects such as wound healing and improvement of symptoms such as burns.
[0005] 本発明は、安全性が高ぐコラーゲン合成作用等に優れた発酵物組成物を提供す ることを目的とする。また、本発明は、該発酵物組成物を含む化粧品組成物を提供 することを目的とする。更に、本発明は、上記発酵物組成物及び化粧品組成物の製 造方法を提供することを目的とする。 [0005] An object of the present invention is to provide a fermented product composition excellent in collagen synthesizing action and the like with high safety. The present invention also provides a cosmetic composition comprising the fermented composition. The purpose is to do. Furthermore, an object of this invention is to provide the manufacturing method of the said fermented material composition and cosmetics composition.
課題を解決するための手段  Means for solving the problem
[0006] 本発明は以下のとおりである。  [0006] The present invention is as follows.
〔1〕米ぬ力、と豆類由来ペプチドとを枯草菌により発酵させて得られる発酵物と、ぺ プチド及びビタミン A類の少なくとも 1種と、を含有することを特徴とする発酵物組成物  [1] A fermented product composition comprising a fermented product obtained by fermenting rice bran strength and a bean-derived peptide with Bacillus subtilis, and at least one of peptides and vitamins A
〔2〕上記ペプチドは、大豆タンパク質が加水分解されたペプチド及びシルクフイブ 口インの少なくとも 1種である上記〔1〕記載の発酵物組成物。 [2] The fermented product composition according to the above [1], wherein the peptide is at least one of a peptide obtained by hydrolyzing soybean protein and silk fiber mouth-in.
〔3〕上記〔1〕記載の発酵物組成物を含有することを特徴とする化粧品組成物。 [3] A cosmetic composition comprising the fermented product composition described in [1] above.
〔4〕米ぬ力と豆類由来ペプチドとを枯草菌により発酵させて得られる発酵物とぺプ チド及びビタミン A類の少なくとも 1種とを混合する混合工程を備えることを特徴とする 発酵物組成物の製造方法。 [4] A fermented product composition comprising a mixing step of mixing fermented material obtained by fermenting rice bran and bean-derived peptides with Bacillus subtilis and at least one of peptide and vitamin A Manufacturing method.
〔5〕米ぬ力と豆類由来ペプチドとを枯草菌により発酵させて得られる発酵物とぺプ チド及びビタミン A類の少なくとも 1種とを混合する混合工程と、該混合工程において 得られる発酵物組成物を製剤化して化粧品組成物を得る工程と、を備えることを特徴 とする化粧品組成物の製造方法。  [5] A mixing step of mixing a fermented product obtained by fermenting rice bran and bean-derived peptides with Bacillus subtilis and at least one of peptides and vitamin A, and a fermented product obtained in the mixing step And a step of formulating the composition to obtain a cosmetic composition. A method for producing a cosmetic composition, comprising:
発明の効果  The invention's effect
[0007] 本発明の発酵物組成物は、天然物を原料としている。よって、本発明の発酵物組 成物は、安全性が高ぐ且つ優れたコラーゲン合成作用及び細胞増殖作用等を有 する。  [0007] The fermented product composition of the present invention uses a natural product as a raw material. Therefore, the fermented product composition of the present invention has high safety and excellent collagen synthesis action and cell growth action.
更に、上記ペプチドが、大豆タンパク質が加水分解されたペプチド及びシノレクフィ プロインの少なくとも 1種である場合は、より入手が容易であり、且つ十分なコラーゲン 合成性等を有する発酵物組成物とすることができる。  Further, when the peptide is at least one of a peptide obtained by hydrolyzing soy protein and synolephifiproin, a fermented product composition that is more easily available and has sufficient collagen synthesis properties, etc. it can.
本発明の化粧品組成物は、上記構成を有することにより、優れたコラーゲン合成作 用及び細胞増殖作用を奏する。  The cosmetic composition of the present invention has an excellent collagen synthesis action and cell proliferation action by having the above-described configuration.
本発明の発酵物組成物及び化粧品組成物の製造方法によれば、入手が容易な枯 草菌を用いて発酵させることにより製造できる。よって、上記の優れた作用を有する 本発明の発酵物組成物等を、小型の製造設備により安全に、且つ容易に製造するこ とができる。 According to the method for producing a fermented product composition and a cosmetic composition of the present invention, the fermented product composition and the cosmetic composition can be produced by fermentation using Bacillus subtilis which is easily available. Therefore, it has the above-mentioned excellent action The fermented product composition of the present invention can be produced safely and easily with a small production facility.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0008] 以下、本発明を詳しく説明する。  [0008] Hereinafter, the present invention will be described in detail.
(1)発酵物組成物  (1) Fermented product composition
本発明の発酵物組成物は、米ぬかと豆類由来ペプチドとを枯草菌により発酵させ て得られる発酵物と、ペプチド及びビタミン A類の少なくとも 1種と、を含有することを 特徴とする。  The fermented product composition of the present invention contains a fermented product obtained by fermenting rice bran and a bean-derived peptide with Bacillus subtilis, and at least one of a peptide and vitamin A.
[0009] 上記「米ぬか」としては、例えば、米ぬか、脱脂米ぬか、米胚芽、及び脱脂米胚芽 が挙げられる。これらは 1種単独で用いてもよぐ 2種以上を併用してもよい。上記米 ぬかは、市販の米ぬか等に限定されることなぐ様々な種類の米ぬかを用いることが できる。  [0009] Examples of the "rice bran" include rice bran, defatted rice bran, rice germ, and defatted rice germ. These may be used alone or in combination of two or more. As the rice bran, various types of rice bran can be used without being limited to commercially available rice bran.
[0010] 上記「豆類由来ペプチド」は、豆類に含まれるペプチド又は豆類に含まれるタンパ ク質に由来するペプチドであれば、その具体的な種類及び構造には特に限定はな レ、。上記「豆類由来ペプチド」は、市販の豆類由来ペプチドに限定されることなぐ様 々な種類の豆類由来ペプチドを用いることができる。上記豆類由来ペプチドとしては 、例えば、大豆ペプチド、小豆ペプチド、エンドゥペプチド及びそらまめペプチドが挙 げられる。上記豆類由来ペプチドとしては、大豆ペプチドが好ましい。上記豆類由来 ペプチドは 1種単独で用いてもよぐ 2種以上を併用してもよい。  [0010] The above-mentioned "bean-derived peptide" is not particularly limited in its specific type and structure as long as it is a peptide contained in beans or a peptide derived from proteins contained in beans. As the “bean-derived peptide”, various kinds of bean-derived peptides can be used without being limited to commercially available bean-derived peptides. Examples of the bean-derived peptide include soybean peptide, red bean peptide, endo peptide and broad bean peptide. As the bean-derived peptide, soybean peptide is preferable. The legume-derived peptides may be used alone or in combination of two or more.
[0011] 上記豆類由来ペプチドを得る方法には特に限定はない。例えば、上記豆類由来ぺ プチドは、豆類 (例えば、大豆、小豆、エンドゥ及びそらまめ等の 1種又は 2種以上)を 溶媒 (水、熱水、アルコール (エタノール等)の有機溶媒又は水一有機溶媒混合溶媒 )で抽出することにより得ることができる。この過程において、必要に応じて分画及び 精製等を行うことができる。更に、プロテアーゼ、酸又はアルカリで加水分解処理をす ることにより、得られた豆類由来ペプチド又は豆類タンパク質を更に断片化することが できる。更に、上記豆類由来ペプチドは、化学的にアミノ酸同士をペプチド結合させ ることにより、あるいは公知の遺伝子工学的手法により、人為的に合成されたぺプチ ドでちよレヽ。 [0012] 上記豆類由来ペプチドの形態には特に限定はない。上記豆類由来ペプチドは、上 記抽出後、乾燥等により固形化した固形物 (例えば、粉状物又は粒状物等)とするこ とができる。また、上記豆類由来ペプチドとして、上記抽出物自体を用いることができ る。即ち、本発明では、上記豆類由来ペプチドとして、上記豆類由来ペプチドを含有 する抽出物(豆類エキス、特に大豆エキス等)を用いることができる。例えば、本発明 では、上記豆類由来ペプチドとして、豆類 (例えば、大豆、小豆、エンドゥ及びそらま め等の 1種又は 2種以上)を溶媒 (水、熱水、アルコール (エタノール等)の有機溶媒 又は水一有機溶媒混合溶媒)で抽出することにより得られる抽出物を用いることがで きる。本発明では、特に大豆ペプチドを含有する抽出物(大豆エキス)等が好ましく用 いられる。 [0011] There is no particular limitation on the method for obtaining the bean-derived peptide. For example, the above-mentioned peptides derived from beans are made of beans (for example, one or more of soybeans, red beans, endu and broad beans) as solvents (water, hot water, organic solvents such as alcohol (ethanol etc.) or water-one organic solvents. It can be obtained by extraction with a mixed solvent. In this process, fractionation and purification can be performed as necessary. Furthermore, the obtained legume-derived peptide or legume protein can be further fragmented by subjecting it to a hydrolysis treatment with protease, acid or alkali. Furthermore, the above-mentioned bean-derived peptide is an artificially synthesized peptide obtained by chemically peptide-binding amino acids or by a known genetic engineering technique. [0012] There is no particular limitation on the form of the legume-derived peptide. The bean-derived peptide can be made into a solid (eg, a powdery product or a granular product) solidified by drying or the like after the above extraction. Moreover, the said extract itself can be used as said bean-derived peptide. That is, in the present invention, an extract containing a bean-derived peptide (bean extract, particularly soybean extract) can be used as the bean-derived peptide. For example, in the present invention, as the above-mentioned bean-derived peptide, beans (for example, one or more of soybeans, red beans, endu, and broad beans) are used as solvents (water, hot water, alcohol (ethanol, etc.) organic solvents. Alternatively, an extract obtained by extraction with a water-organic solvent mixed solvent) can be used. In the present invention, an extract (soybean extract) containing soybean peptide is particularly preferably used.
[0013] 上記豆類由来ペプチドを含有する抽出物を得るための抽出方法、抽出条件につい ては特に限定はない。例えば、抽出原料である豆類は未粉砕でも、粉砕したものでも よい。また、抽出物の品質を維持できる限り、不純物除去等の前処理をしてもよい。ま た、抽出溶媒としては、水又は熱水の他、メタノール及びエタノール等のアルコール 、酢酸ェチル等のエステル、 n キサン等の有機溶媒、並びにこれらの有機溶媒と 水又は熱水との混合溶媒等を用いることができる。上記抽出溶媒としては、水又は熱 水、アルコール(メタノール及びエタノール等)、及び水又は熱水とアルコールとの混 合溶媒が好ましい。上記熱水の温度は、通常、 40〜: 100°C、好ましくは 50 80°C 更に好ましくは 50 70°Cである。また、抽出の際の抽出溶媒の pHは通常 3 7、好 ましくは 4 6、更に好ましくは 4 5である。 pHを上記範囲内とすることにより、抽出 原料に含まれている各種成分の安定性を保つことができるので好ましい。抽出温度 は特に制限されないが、常温又は加熱抽出が好ましい。加熱抽出の場合、加熱温度 としては通常 40〜: 100°C、好ましくは 50 80°C、更に好ましくは 50 70 Cである。 加熱温度を力かる範囲とすることにより、抽出を効率的に行うことができるので好まし レ、。  [0013] There are no particular limitations on the extraction method and extraction conditions for obtaining an extract containing the bean-derived peptide. For example, beans that are extraction raw materials may be unground or pulverized. Further, as long as the quality of the extract can be maintained, pretreatment such as impurity removal may be performed. Examples of the extraction solvent include water or hot water, alcohols such as methanol and ethanol, esters such as ethyl acetate, organic solvents such as n-xane, mixed solvents of these organic solvents and water or hot water, and the like. Can be used. As the extraction solvent, water or hot water, alcohol (such as methanol and ethanol), and a mixed solvent of water or hot water and alcohol are preferable. The temperature of the hot water is usually 40 to 100 ° C, preferably 50 80 ° C, more preferably 50 70 ° C. In addition, the pH of the extraction solvent during extraction is usually 37, preferably 46, and more preferably 45. It is preferable to adjust the pH within the above range since the stability of various components contained in the extraction raw material can be maintained. The extraction temperature is not particularly limited, but normal temperature or heat extraction is preferable. In the case of heat extraction, the heating temperature is usually 40 to 100 ° C, preferably 5080 ° C, more preferably 5070C. It is preferable because the extraction can be performed efficiently by setting the heating temperature within the effective range.
[0014] 上記米ぬ力、と上記豆類由来ペプチドとの割合には特に限定はない。通常、上記豆 類由来ペプチドを 100質量部とした場合に、上記米ぬかの割合は 1 20質量部、好 ましくは 5 20質量部、更に好ましくは 8〜: 18質量部である。上記米ぬかが上記範囲 であれば、十分なコラーゲン合成作用等を有する発酵物を得ることができる。 [0014] There is no particular limitation on the ratio between the above-mentioned rice force and the above-mentioned bean-derived peptide. Usually, when the bean-derived peptide is 100 parts by mass, the ratio of the rice bran is 120 parts by mass, preferably 520 parts by mass, more preferably 8 to 18 parts by mass. The above rice bran is in the above range If so, a fermented product having a sufficient collagen synthesis action and the like can be obtained.
[0015] 上記「枯草菌」 [バチルス ·ズブチルス(Bacillus subtilis) ]は、好気性胞子形成 細菌の代表的な種類である。上記枯草菌の種類は、安全性が保証されている限り特 に限定されない。上記枯草菌としては、例えば、納豆菌レ チルス ·ナツトウ(Bacillus natto) ]等を用いることができる。上記枯草菌としては、入手が容易であり、且つ安 価である納豆菌が好ましい。尚、上記枯草菌としては、市販されている一般的な枯草 菌を用いることができる。また、コラーゲン合成作用等を有する発酵物が得られる限り 、上記枯草菌としては、 自然的に、又はニトロソグァ二ジン等の化学物質、 X線及び 紫外線等により人為的な変異手段により生成し、菌学的性質が変異した変異株も用 レ、ることができる。  [0015] The above-mentioned "Bacillus subtilis" [Bacillus subtilis] is a typical kind of aerobic spore-forming bacteria. The type of Bacillus subtilis is not particularly limited as long as safety is guaranteed. As the Bacillus subtilis, for example, Bacillus natto can be used. As the Bacillus subtilis, Bacillus natto that is easily available and inexpensive is preferable. As the Bacillus subtilis, commercially available general Bacillus subtilis can be used. As long as a fermented product having a collagen synthesizing action or the like is obtained, the Bacillus subtilis may be produced naturally or by a chemical substance such as nitrosoguanidine, X-rays, ultraviolet rays, etc. Mutants with altered chemistry can also be used.
[0016] 上記「発酵物」は、上記米ぬかと上記豆類由来ペプチドとを枯草菌により発酵させ て得られる。上記発酵物は通常、上記米ぬか及び上記豆類由来ペプチドを含む培 地に枯草菌を摂取し、適切な条件で発酵培養することにより得られる。上記「発酵物」 を得るための発酵培養条件には特に限定はない。発酵培養は通常、通気攪拌を行う ことにより行われる。また、上記培地についても、上記枯草菌が増殖できる限り特に制 限はない。上記培地は通常は液体培地である力 固形培地でも力まわない。また、 上記培地の pH (特に発酵時)は、通常 5. 5〜8. 5、好ましくは 6. 0〜8. 0、更に好ま しくは 6. 5〜7· 5である。この pHを上記の範囲内とすると、抽出原料に含まれている 各種成分の安定性を保つことができるので好ましい。更に、培養温度についても、発 酵が行われる限り特に制限はない。該培養温度は、通常 15〜50°C、好ましくは 20 〜45°C、更に好ましくは 30〜45°C、より好ましくは 35〜43°Cである。また、糖等の各 種の栄養素並びに pH調製のための酸及びアルカリ等を培地に添カ卩してもよレ、。更 に、上記発酵は、混合発酵でも連続発酵でもよい。  [0016] The "fermented product" is obtained by fermenting the rice bran and the bean-derived peptide with Bacillus subtilis. The fermented product is usually obtained by ingesting Bacillus subtilis into a medium containing the rice bran and the beans-derived peptide and fermenting and culturing under appropriate conditions. The fermentation culture conditions for obtaining the above “fermented product” are not particularly limited. Fermentation culture is usually performed by aeration and agitation. The medium is not particularly limited as long as the Bacillus subtilis can grow. The medium is usually a liquid medium, but it cannot be a solid medium. The pH of the medium (especially during fermentation) is usually 5.5 to 8.5, preferably 6.0 to 8.0, and more preferably 6.5 to 7.5. If this pH is within the above range, it is preferable because the stability of various components contained in the extraction raw material can be maintained. Further, the culture temperature is not particularly limited as long as fermentation is performed. The culture temperature is usually 15 to 50 ° C, preferably 20 to 45 ° C, more preferably 30 to 45 ° C, and more preferably 35 to 43 ° C. In addition, various nutrients such as sugar and acid and alkali for pH adjustment may be added to the medium. Further, the fermentation may be mixed fermentation or continuous fermentation.
[0017] 上記発酵物の形態には特に限定はない。上記発酵物は、発酵培養により得られた 発酵液又は該発酵液をろ過したままの液でもよい。また、上記発酵物は、上記発酵 液に対し、必要に応じて滅菌処理若しくは pH調整をしたり、又はイオン交換樹脂、活 性炭カラム若しくは透析膜等を利用し、脱臭 ·脱色等の後処理をした発酵液でもよい 。更に、上記発酵物は、該発酵液を濃縮した濃縮液又はペースト状物でもよい。その 他にも、上記発酵物は、該発酵液を凍結乾燥等の公知の方法により溶媒を除去した 固形物及び粉末化した粉末物でもよい。更に、上記発酵物は、上記発酵液又は上 記固形物及び粉末物を、水若しくはエタノール、プロピレングリコール及び 1 , 3—ブ チレングリコール等の有機溶媒、又はこれらの混合溶媒に添加した溶液又は分散液 としてもよレ、。 [0017] The form of the fermented product is not particularly limited. The fermented product may be a fermented liquid obtained by fermentation culture or a liquid obtained by filtering the fermented liquid. In addition, the fermented product is sterilized or pH-adjusted as necessary with respect to the fermented liquid, or after-treatment such as deodorization / decolorization using an ion exchange resin, an activated charcoal column or a dialysis membrane. Fermented broth may be used. Further, the fermented product may be a concentrated solution or a paste-like product obtained by concentrating the fermented solution. That In addition, the fermented product may be a solid product or a powdered product obtained by removing the solvent from the fermented solution by a known method such as freeze drying. Further, the fermented product is a solution or dispersion obtained by adding the fermented liquid or the solid and powdered materials to water or an organic solvent such as ethanol, propylene glycol and 1,3-butylene glycol, or a mixed solvent thereof. You can also use it as a liquid.
[0018] 上記「ペプチド」は、アミノ酸がペプチド結合により結合したポリペプチドである。尚、 上記アミノ酸は、通常は L—アミノ酸である力 D—アミノ酸でもよぐあるいは両者の 混合物でもよい。即ち、上記ペプチドを構成するアミノ酸は、 L-アミノ酸、 D—ァミノ 酸及び両者の混合のレ、ずれでもよレ、。  [0018] The "peptide" is a polypeptide in which amino acids are bound by peptide bonds. The amino acid may be a force D-amino acid, which is usually an L-amino acid, or a mixture of both. That is, the amino acids constituting the peptide are L-amino acids, D-amino acids, and a mixture of both, or may be shifted.
[0019] 上記ペプチドの種類、由来、及び構造には特に限定はない。例えば、上記べプチ ドは、植物に含まれる植物由来のペプチドでもよぐ動物に含まれる動物由来のぺプ チドでもよレ、。また、上記ペプチドの構造も、直鎖構造のみならず、ジスルフイド結合 を含んでいてもよい。上記ペプチドとして具体的には、例えば、大豆タンパク質 (大豆 に含まれるタンパク質)を加水分解することにより得られるペプチド及びシルクフイブ口 イン等の絹ペプチド(絹に含まれるペプチド及び絹に含まれるタンパク質を加水分解 して得られるペプチド)等が挙げられる。これらのペプチドを用いると、優れたコラーゲ ン合成作用及び細胞増殖作用等を有する発酵物組成物を得ることができる。  [0019] The type, origin, and structure of the peptide are not particularly limited. For example, the peptide may be a plant-derived peptide contained in a plant or an animal-derived peptide contained in an animal. Moreover, the structure of the peptide may include not only a linear structure but also a disulfide bond. Specific examples of the peptide include, for example, peptides obtained by hydrolyzing soy protein (proteins contained in soybean) and silk peptides such as silk-five phine (the peptides contained in silk and the proteins contained in silk are hydrolyzed. Peptide obtained by degradation). By using these peptides, it is possible to obtain a fermented product composition having an excellent collagen synthesis effect and cell proliferation effect.
[0020] 上記ペプチドを得る方法には特に限定はない。上記ペプチドは通常、各種のタン パク質をプロテアーゼ、酸、又はアルカリ等によって加水分解することにより得ること ができる。勿論、具体的な加水分解の方法及び条件には特に限定はない。ここで、 上記タンパク質の種類には特に限定はない。上記タンパク質として、例えば、大豆タ ンパク質及び絹に含まれる絹タンパク質が挙げられる。また、上記ペプチドとして、化 学的にアミノ酸同士をペプチド結合させることにより、あるいは公知の遺伝子工学的 手法により、人為的に合成されたペプチドを用いることもできる。 [0020] The method for obtaining the peptide is not particularly limited. The above peptides can usually be obtained by hydrolyzing various proteins with protease, acid, alkali or the like. Of course, the specific hydrolysis method and conditions are not particularly limited. Here, the kind of the protein is not particularly limited. Examples of the protein include soy protein and silk protein contained in silk. Further, as the above peptide, a peptide artificially synthesized by chemically bonding amino acids to each other or by a known genetic engineering technique can be used.
[0021] 上記ペプチドのアミノ酸数及び分子量も特に限定はなレ、。上記ペプチドのアミノ酸 数の下限は、例えば 2、 3又は 4とすることができる。また、上記ペプチドのアミノ酸数 の上限は、例えば、 100、 80、 60又は 40とすること力できる。上記ペプチドの分子量 の下限は、例えば、 50、 100又は 200とすること力 Sできる。また、上記ペプチドの分子 量の上限としては、 f列えば、、 300000、 200000、 100000、 50000又は 30000とす ること力 Sできる。特に細胞増殖作用を目的とする場合は、上記ペプチドとして、高分 子量のペプチド、例えば、分子量が 40000以上のペプチドを用いることが好ましい。 尚、上記ペプチドの分子量は公知の各種の方法により測定することができる。上記べ プチドの分子量は、例えば、 SDS— PAGEによる電気泳動法及び HPLCとカラムと によるゲルろ過クロマトグラフィー等によって測定することができる。上記ペプチドのァ ミノ酸数及び分子量は、タンパク質又はペプチドをプロテアーゼ、酸、又はアルカリ等 によって加水分解することにより適宜調節することができる。 [0021] The number of amino acids and the molecular weight of the peptide are not particularly limited. The lower limit of the number of amino acids of the peptide can be set to 2, 3, or 4, for example. Further, the upper limit of the number of amino acids of the peptide can be, for example, 100, 80, 60, or 40. The lower limit of the molecular weight of the peptide can be set to 50, 100 or 200, for example. In addition, the peptide molecule As the upper limit of quantity, if it is column f, it can be set to 300000, 200000, 100000, 50000 or 30000. In particular, for the purpose of cell proliferation action, it is preferable to use a high molecular weight peptide, for example, a peptide having a molecular weight of 40,000 or more as the peptide. The molecular weight of the peptide can be measured by various known methods. The molecular weight of the peptide can be measured by, for example, electrophoresis using SDS-PAGE and gel filtration chromatography using HPLC and a column. The amino acid number and molecular weight of the peptide can be appropriately adjusted by hydrolyzing the protein or peptide with a protease, acid, alkali, or the like.
[0022] 上記ペプチドとして好ましくは、 (1)分子量が 200〜200000のペプチド、(2)ァミノ 酸数が 4〜40であり、且つ分子量が 220〜8000であるペプチド、及び(3)アミノ酸数 力 ¾〜3であり、且つ分子量が 100以下、 100〜250及び 250〜500の分子量の異 なるペプチドの混合物である。また、これら(1)〜(3)のペプチドとして、シルクフイブ 口インがより好ましい。これらのペプチドと上記発酵物とを含有させることにより、発酵 物のみを含有するときに比べて、より優れたコラーゲン合成作用及び細胞増殖作用 等を有する発酵物組成物を得ることができる。 [0022] The peptide is preferably (1) a peptide having a molecular weight of 200 to 200,000, (2) a peptide having an amino acid number of 4 to 40 and a molecular weight of 220 to 8000, and (3) an amino acid number force. A mixture of peptides having different molecular weights of ¾ to 3 and molecular weights of 100 or less, 100 to 250, and 250 to 500. Further, as these peptides (1) to (3), silk fiber mouth-in is more preferable. By containing these peptides and the fermented product, it is possible to obtain a fermented product composition having superior collagen synthesizing action, cell proliferating action, and the like as compared with the case of containing only the fermented product.
[0023] また、上記ペプチドとしては、大豆タンパク質が加水分解されたものであり、アミノ酸 数が 2〜6、且つ分子量が 100〜1200であるペプチドも好ましレ、。この大豆タンパク 質を用いたペプチドと発酵物とを含有させることにより、発酵物のみを含有するときに 比べて、より優れたコラーゲン合成作用及び細胞増殖作用等を有する発酵物組成物 とすることができる。 [0023] Further, as the peptide, a peptide obtained by hydrolyzing soy protein, having 2 to 6 amino acids and having a molecular weight of 100 to 1200 is preferable. By containing a peptide using this soy protein and a fermented product, it is possible to obtain a fermented product composition having superior collagen synthesizing action, cell proliferating action, etc., compared to the case of containing only fermented product. it can.
[0024] 上記ペプチドは 1種単独で用いてもよぐ 2種以上を用いてもよい。例えば、上記べ プチドとしては、上記の各種のペプチドのうちの 1種のみを用いてもよいし、 2種以上 を併用してもよい。また、上記ペプチドとして、アミノ酸数及び/又は分子量が異なる 2種以上のペプチドを含んでいてもよい。更に、上記ペプチドとして、大豆タンパク質 が加水分解されてなるペプチド及びシノレタフイブ口イン等の絹ペプチドのように、種類 が異なるペプチドの 2種以上を併用することもできる。  [0024] The above peptides may be used alone or in combination of two or more. For example, as the peptide, only one of the various peptides described above may be used, or two or more may be used in combination. Moreover, as said peptide, 2 or more types of peptides from which an amino acid number and / or molecular weight differ may be included. Furthermore, as the above-mentioned peptide, two or more kinds of peptides of different kinds, such as a peptide obtained by hydrolyzing soy protein and a silk peptide such as sinoretafive mouth-in, can be used in combination.
[0025] 上記「ビタミン A類」は、イソプレノイド型ポリェンアルコールを基本骨格として有する 化合物及び該化合物の誘導体である。上記ビタミン A類として具体的には、例えば、 ビタミン Al (レチノール)、ビタミン A2、ビタミン A3及び 3, 4—ジヒドロレチノール並び にこれらが酸化されたアルデヒド(レチナール等)及びカルボン酸(レチノイン酸)等が 挙げられる。また、上記「ビタミン A類」には、薬学的に許容される塩及び薬学的に許 容される誘導体をも含む。上記誘導体としては、例えば、上記レチノール等のカルボ ン酸エステルが挙げられる。上記誘導体としてより具体的には、例えば、酢酸レチノ ール及びパルミチン酸レチノール等の C1〜C30エステル等が挙げられる。尚、本発 明では、上記ビタミン類は 1種単独で用いてもよぐ 2種以上を併用してもよい。 [0025] The above-mentioned "Vitamin A" is a compound having an isoprenoid-type polyalcohol as a basic skeleton and a derivative of the compound. Specific examples of vitamin A include, for example, Examples include vitamin Al (retinol), vitamin A2, vitamin A3, and 3,4-dihydroretinol, as well as aldehydes (retinal and the like) and carboxylic acids (retinoic acid) and the like which are oxidized. The “vitamins A” include pharmaceutically acceptable salts and pharmaceutically acceptable derivatives. Examples of the derivatives include carboxylic acid esters such as the above retinol. More specifically, examples of the derivative include C1-C30 esters such as retinoyl acetate and retinol palmitate. In the present invention, the above vitamins may be used alone or in combination of two or more.
[0026] 本発明において、上記ビタミン A類の含有形態には特に限定はなレ、。上記ビタミン A類自体を本発明の発酵物組成物に含有させてもよぐその他の物質と併用して含 有させてもよい。例えば、上記ビタミン A類は、シクロデキストリン等のホストイ匕合物に 包接させた包接化合物として、本発明の発酵物組成物に含有させることができる。ま た、上記ビタミン A類は、上記ビタミン A類を含む組成物又は混合物として、本発明の 発酵物組成物に含有させることができる。例えば、上記ビタミン A類は、肝油等の上 記ビタミン A類を含有する組成物として、本発明の発酵物組成物に含有させることが できる。更に、上記ビタミン A類は、上記ビタミン A類が溶解又は分散した溶液又は分 散液として、本発明の発酵物組成物に含有させることができる。例えば、上記ビタミン A類を動物油又は植物油に溶解させ、当該溶液を本発明の発酵物組成物に含有さ せること力 Sできる。 [0026] In the present invention, there is no particular limitation on the form of the vitamin A. The vitamin A itself may be contained in combination with other substances that may be contained in the fermented product composition of the present invention. For example, the vitamin A can be contained in the fermented product composition of the present invention as an inclusion compound included in a host compound such as cyclodextrin. The vitamin A can be contained in the fermented product composition of the present invention as a composition or mixture containing the vitamin A. For example, the vitamin A can be contained in the fermented product composition of the present invention as a composition containing the vitamin A such as liver oil. Furthermore, the vitamin A can be contained in the fermented product composition of the present invention as a solution or dispersion in which the vitamin A is dissolved or dispersed. For example, the vitamin A can be dissolved in animal oil or vegetable oil, and the solution can be contained in the fermented product composition of the present invention.
[0027] 本発明の発酵物組成物において、上記発酵物と上記ペプチド及び上記ビタミン A 類との割合には特に限定はなレ、。上記発酵物と上記ペプチド及び上記ビタミン A類と の合計を 100質量%とした場合に、上記発酵物の割合は、通常 0. :!〜 99. 9質量% 、好ましくは 10〜80質量%、更に好ましくは 40〜60質量%である。本発明では、上 記発酵物と上記ペプチド及び上記ビタミン A類の 1種又は 2種以上とを含有すること により、コラーゲン合成作用等が向上する。本発明では、上記発酵物と上記ペプチド 及び上記ビタミン A類の 1種又は 2種以上の各々の含有量に大差がない場合、即ち、 上記発酵物の質量割合が 40〜60質量%であるときは、コラーゲン合成作用等がより 向上するため好ましい。  [0027] In the fermented product composition of the present invention, the ratio of the fermented product to the peptide and the vitamin A is not particularly limited. When the total of the fermented product, the peptide and the vitamin A is 100% by mass, the ratio of the fermented product is usually 0.:!-99.9% by mass, preferably 10-80% by mass, More preferably, it is 40-60 mass%. In the present invention, the collagen synthesis action or the like is improved by containing the fermented product, one or more of the above peptides and vitamin A. In the present invention, when the content of each of one or more of the fermented product, the peptide, and the vitamin A is not greatly different, that is, when the mass ratio of the fermented product is 40 to 60% by mass. Is preferable because the collagen synthesis action and the like are further improved.
[0028] 本発明の発酵物組成物は、各種の用途に用いることができる。この用途には特に 限定はない。本発明の発酵物組成物は、例えば、皮膚外用剤等の化粧品、化粧品 素材、飲食物、飲食物用添加剤及び入浴剤等に用いることができる。 [0028] The fermented product composition of the present invention can be used for various applications. Especially for this application There is no limitation. The fermented product composition of the present invention can be used, for example, for cosmetics such as external preparations for skin, cosmetic materials, foods and drinks, food and drink additives, bathing agents, and the like.
[0029] 本発明の発酵物組成物は、化粧品及び飲食物等に配合することができる。化粧品 に配合する場合、本発明の発酵物組成物の配合量には特に限定はない。該配合量 は、化粧品の種類等により適量を配合することができる。本発明の発酵物組成物の 配合量は、化粧品を 100質量%とした場合に、 0. 001〜: 100質量%、特に 0. 001 〜50質量%とすることができる。本発明の発酵物組成物の含有量が上記範囲内で あれば、優れたコラーゲン合成作用等を有する化粧品とすることができる。  [0029] The fermented product composition of the present invention can be blended in cosmetics, foods and drinks, and the like. When blended in cosmetics, the blended amount of the fermented product composition of the present invention is not particularly limited. The blending amount can be blended in an appropriate amount depending on the type of cosmetics. The blending amount of the fermented product composition of the present invention can be 0.001 to 100% by mass, especially 0.001 to 50% by mass when the cosmetic is 100% by mass. When the content of the fermented product composition of the present invention is within the above range, a cosmetic product having an excellent collagen synthesis action and the like can be obtained.
[0030] 本発明の発酵物組成物を配合することができる化粧品の種類も特に限定はない。  [0030] The types of cosmetics to which the fermented product composition of the present invention can be blended are not particularly limited.
該化粧品としては、例えば、フリーズドライ、パック、パックシート、ピーリング、パウダ 一、化粧水、おしろレ、、固形おしろい、口紅、固形頰紅、ファンデーションクリーム、乳 液、ローション、ボディローション、クレンジングローション、洗顔クリーム、スキンケアク リーム、ヘアーリンス、ヘアーリキッド、アイシャドウ及び眉ずみ等が挙げられる。また、 これらの化粧品には、その種類により、必要に応じて、他の成分、例えば、植物ェキ ス、ビタミン、ビタミン様物質、ミネラル、低級アルコール類、多価アルコール類、油脂 類、界面活性剤、抗酸化剤、紫外線吸収剤、増粘剤、色素、防腐剤及び香料等を添 カロすることちでさる。  The cosmetics include, for example, freeze-drying, packs, pack sheets, peeling, powders, lotions, white towels, solid white lipsticks, lipsticks, solid scarlet, foundation creams, emulsions, lotions, body lotions, cleansing lotions. , Face washing cream, skin care cream, hair rinse, hair liquid, eye shadow and eyebrows. Depending on the type of these cosmetics, other ingredients such as plant sex, vitamins, vitamin-like substances, minerals, lower alcohols, polyhydric alcohols, oils and fats, surfactants are used as necessary. This can be done by adding additives, antioxidants, UV absorbers, thickeners, pigments, preservatives, and fragrances.
[0031] 本発明の発酵物組成物を配合する化粧品としては、特に皮膚外用剤が挙げられる 。本発明の発酵物組成物は優れたコラーゲン合成作用等を有する。よって、本発明 の発酵物組成物は、皮膚に塗布して用いる化粧品に特に有用である。本発明の発 酵物組成物を有効成分として含有する皮膚外用剤は、本発明の発酵物組成物と、 皮膚外用剤に用いられる他の配合剤とを用いて調製することができる。上記他の配 合剤としては、例えば液体油(スクヮラン及びホホバ油等)、固体油(ミツロウ及びセチ ルアルコール等)、各種の活性剤、並びに保湿剤(グリセリン及び 1 , 3—ブチレンダリ コール等)が挙げられる。この皮膚外用剤の剤形には特に限定はない。この皮膚外 用剤は、例えば、ローション、クリーム及び乳液等、 目的に応じて種々の剤形とするこ とができる。この皮膚外用剤において、本発明の発酵物組成物の配合量には特に限 定はない。本発明の発酵物組成物の配合量は、皮膚外用剤を 100質量%とした場 合に、 0· 001〜100質量%、特に 0· 001〜50質量%とすることができる。本発明の 発酵物組成物の含有量が上記範囲内であれば、優れたコラーゲン合成作用等を有 する皮膚外用剤とすることができる。 [0031] Examples of cosmetics containing the fermented product composition of the present invention include skin external preparations. The fermented product composition of the present invention has an excellent collagen synthesis action and the like. Therefore, the fermented product composition of the present invention is particularly useful for cosmetics used by applying to the skin. The external preparation for skin containing the fermented product composition of the present invention as an active ingredient can be prepared using the fermented product composition of the present invention and other compounding agents used for the external skin preparation. Examples of other binders include liquid oil (such as squalane and jojoba oil), solid oil (such as beeswax and cetyl alcohol), various activators, and humectants (such as glycerin and 1,3-butylene alcohol). Is mentioned. There is no particular limitation on the dosage form of the external preparation for skin. This external preparation for skin can be made into various dosage forms according to the purpose, such as lotion, cream and emulsion. In this external preparation for skin, the blending amount of the fermented product composition of the present invention is not particularly limited. The amount of the fermented product composition of the present invention is 100% by mass when the external preparation for skin is 100% by mass. In other words, the content can be set to 0.001 to 100% by mass, particularly 0.001 to 50% by mass. If the content of the fermented product composition of the present invention is within the above range, it can be used as a skin external preparation having an excellent collagen synthesis action and the like.
[0032] 本発明の発酵物組成物を含む飲食物は、例えば、本発明の発酵物組成物を他の 食品原料とともに混合し、又は予め混合された食品原料混合物に本発明の発酵物 組成物を配合し、次いで、一般的な方法により加工して製造することができる。本発 明の発酵物組成物を含む飲食物は、例えば、油脂、エタノール、プロピレングリコー ノレ、グリセリン又はこれらの混合物に本発明の発酵物組成物を溶解させ、これを飲料 又は固形食品に配合することにより製造することができる。また、本発明の発酵物組 成物を含む飲食物は、本発明の発酵物組成物と、アラビアガム及びデキストリン等の バインダーとを混合して粉末又は顆粒等とし、これを飲料又は固形食品に配合するこ とにより製造することができる。本発明の発酵物組成物を含む飲食物は、健康食品及 び機能性食品等として提供することができる。  [0032] The food and drink containing the fermented product composition of the present invention includes, for example, the fermented product composition of the present invention mixed with other food raw materials or a premixed food raw material mixture of the fermented product composition of the present invention. And then processed by a general method. The food and drink containing the fermented product composition of the present invention is prepared by, for example, dissolving the fermented product composition of the present invention in fats and oils, ethanol, propylene glycol, glycerin or a mixture thereof, and blending it into beverages or solid foods. Can be manufactured. In addition, foods and drinks containing the fermented product composition of the present invention are prepared by mixing the fermented product composition of the present invention with a binder such as gum arabic and dextrin to form a powder or granules, which are used as beverages or solid foods. It can be manufactured by blending. Foods and drinks containing the fermented product composition of the present invention can be provided as health foods and functional foods.
[0033] 尚、本発明の発酵物組成物を配合した配合物を、化粧品素材、入浴剤、及び飲食 物用添加剤等として用いることもできる。  [0033] It should be noted that a blend containing the fermented product composition of the present invention can also be used as a cosmetic material, a bath agent, an additive for food and drink, and the like.
[0034] (2)化粧品組成物、細胞賦活用皮膚外用剤組成物及び化粧品原料  [0034] (2) Cosmetic composition, cell-applied skin external preparation composition, and cosmetic raw material
本発明の化粧品組成物、細胞賦活用皮膚外用剤組成物及び化粧品原料は、本発 明の発酵物組成物を含有することを特徴とする。本発明の化粧品組成物、細胞賦活 用皮膚外用剤組成物及び化粧品原料に含まれる上記発酵物組成物については、 既に説明した内容が適用される。  The cosmetic composition, cell-utilized skin external preparation composition and cosmetic raw material of the present invention are characterized by containing the fermented product composition of the present invention. The contents already described apply to the cosmetic composition, the skin external preparation composition for cell activation, and the fermented composition contained in the cosmetic raw material of the present invention.
[0035] 本発明の化粧品組成物、細胞賦活用皮膚外用剤組成物及び化粧品原料における 上記発酵物組成物の割合には特に限定はない。上記発酵物組成物の割合は、例え ば、本発明の化粧品組成物、細胞賦活用皮膚外用剤組成物及び化粧品原料全体 を 100質量0 /0とした場合に、 0. 001〜100質量0 /0、特に 0. 001〜50質量0 /0とする こと力 sできる。上記発酵物組成物の割合が上記範囲内であれば、優れたコラーゲン 合成作用等を有する化粧品組成物、細胞賦活用皮膚外用剤組成物及び化粧品原 料とすることができる。 [0035] The proportion of the fermented composition in the cosmetic composition, cell-utilized skin external preparation composition, and cosmetic raw material of the present invention is not particularly limited. The proportion of the fermented composition For example, the cosmetic composition of the present invention, a cell activator skin external agent composition and the entire cosmetic raw material is 100 mass 0/0, 0.001 to 100 weight 0 / 0, can be this a force s and in particular from 0.001 to 50 mass 0/0. If the proportion of the fermented product composition is within the above range, it can be made into a cosmetic composition having excellent collagen synthesizing action and the like, a cell-utilized skin external preparation composition, and a cosmetic raw material.
[0036] 本発明の化粧品組成物の種類には特に限定はなレ、。上記化粧品組成物としては、 例えば、フリーズドライ、ノ ック、パックシート、ピーリング、おしろレ、、固形おしろい、 口 紅、固形頰紅、ファンデーションクリーム、乳液、ローション、ボディローション、クレン ジングローション、洗顔クリーム、スキンケアクリーム、ヘアーリンス、ヘアーリキッド、ァ ィシャドウ及び眉ずみが挙げられる。また、本発明の化粧品組成物には、その種類に より、必要に応じて他の成分 (例えば、植物エキス、ビタミン、ビタミン様物質、ミネラノレ 、低級アルコール類、多価アルコール類、油脂類、界面活性剤、抗酸化剤、紫外線 吸収剤、増粘剤、色素、防腐剤及び香料)を添加することもできる。 [0036] The type of the cosmetic composition of the present invention is not particularly limited. As the cosmetic composition, For example, freeze-drying, knocking, pack sheet, peeling, white lipstick, solid white, lipstick, solid scarlet, foundation cream, emulsion, lotion, body lotion, cleansing cream, facial cream, skin care cream, hair Rinse, hair liquid, shadow and eyebrows. In addition, the cosmetic composition of the present invention may contain other components (for example, plant extracts, vitamins, vitamin-like substances, mineralols, lower alcohols, polyhydric alcohols, oils and fats, interfaces, depending on the type of the cosmetic composition. Activators, antioxidants, UV absorbers, thickeners, dyes, preservatives and fragrances) can also be added.
[0037] 本発明の化粧品組成物としてより具体的には、特に皮膚外用剤が挙げられる。上 記発酵物組成物は優れたコラーゲン合成作用等を有する。よって、上記発酵物組成 物は、皮膚に塗布して用いる化粧品に特に有用である。上記皮膚外用剤は、上記発 酵物組成物と、皮膚外用剤に用いられる他の配合剤とを用いて調製することができる 。この他の配合剤としては、例えば、液体油(スクヮラン及びホホバ油等)、固体油(ミ ッロウ及びセチルアルコール等)、各種の活性剤、並びに保湿剤(グリセリン及び 1 , 3—ブチレングリコール等)が挙げられる。この皮膚外用剤の剤形には特に限定はな レ、。この皮膚外用剤は、ローション、クリーム及び乳液等、 目的に応じて種々の剤形と すること力 Sできる。この皮膚外用剤において、上記発酵物組成物の配合量には特に 限定はない。上記発酵物組成物の配合量は、皮膚外用剤を 100質量%とした場合 に、 0. 001〜100質量%、特に 0. 001〜50質量%とすることができる。発酵物組成 物の含有量が上記範囲内であれば、優れたコラーゲン合成作用等を有する皮膚外 用剤とすることができる。  [0037] More specifically, the cosmetic composition of the present invention includes a skin external preparation. The fermented product composition has an excellent collagen synthesis action and the like. Therefore, the fermented product composition is particularly useful for cosmetics that are applied to the skin. The said external preparation for skin can be prepared using the said fermented composition and the other compounding agent used for an external preparation for skin. Other compounding agents include, for example, liquid oil (such as squalane and jojoba oil), solid oil (such as micro- and cetyl alcohol), various activators, and humectants (such as glycerin and 1,3-butylene glycol). Is mentioned. There are no particular limitations on the dosage form of this topical skin preparation. This external preparation for skin can be made into various dosage forms according to the purpose, such as lotion, cream and milky lotion. In this external preparation for skin, the amount of the fermented product composition is not particularly limited. The blending amount of the fermented product composition can be 0.001 to 100% by mass, particularly 0.001 to 50% by mass, when the external preparation for skin is 100% by mass. If the content of the fermented product composition is within the above range, it can be used as a skin external preparation having excellent collagen synthesis action and the like.
[0038] 本発明の細胞賦活用皮膚外用剤は、上記発酵物組成物を含む。上記発酵物組成 物は優れたコラーゲン合成作用等を有する。よって、上記発酵物組成物は、皮膚に 塗布して用いる化粧品に配合した場合に特に有用である。本発明の細胞賦活用皮 膚外用剤は、上記皮膚外用剤の説明がそのまま適用できる。  [0038] The cell-stimulated skin external preparation of the present invention contains the fermented product composition. The fermented product composition has an excellent collagen synthesis action and the like. Therefore, the fermented product composition is particularly useful when blended in cosmetics that are applied to the skin. The description of the above-mentioned skin external preparation can be applied as it is to the cell skin external preparation of the present invention.
[0039] 本発明の化粧品原料は、例えば、フリーズドライ、パック、パックシート、ピーリング、 パウダー、化粧水、おしろレ、、固形おしろい、口紅、固形頰紅、ファンデーションタリ ーム、乳液、ローション、ボディローション、クレンジングローション、洗顔クリーム、スキ ンケアクリーム、ヘアーリンス、ヘアーリキッド、アイシャドウ及び眉ずみに配合して用 レ、ることができる。 [0039] The cosmetic raw material of the present invention includes, for example, freeze-drying, packs, pack sheets, peeling, powder, lotion, white lipstick, solid white lipstick, solid red lipstick, foundation tarm, emulsion, lotion, Used in body lotions, cleansing lotions, facial creams, skin care creams, hair rinses, hair liquids, eye shadows and eyebrows I can.
[0040] (3)発酵物組成物等の製造方法  [0040] (3) Method for producing fermented product composition, etc.
本発明の発酵物組成物、化粧品組成物、細胞賦活用皮膚外用剤組成物及び化粧 品原料の製造方法は、米ぬ力、と豆類由来ペプチドとを枯草菌により発酵させて得ら れる発酵物とペプチド及びビタミン A類の少なくとも 1種とを混合する混合工程と、を 備えることを特徴とする。  The fermented product composition, cosmetic composition, cell-utilized skin external preparation composition and cosmetic raw material production method of the present invention are fermented products obtained by fermenting rice bran strength and legume-derived peptides with Bacillus subtilis. And a mixing step of mixing at least one of peptide and vitamin A.
[0041] 上記「米ぬか」、上記「豆類由来ペプチド」、上記「枯草菌」、上記「ペプチド」及び上 記「ビタミン A類」については、本発明の発酵物組成物で説明した内容が適用される [0041] The contents described in the fermented product composition of the present invention are applied to the "rice bran", the "bean-derived peptide", the "Bacillus subtilis", the "peptide" and the "vitamin A". Ru
[0042] 上記「発酵物」は、通常、米ぬかと豆類由来ペプチドとを含有する培地に枯草菌を 接種して発酵させる発酵工程により得られる。上記「発酵工程」における上記「培地」 は、米ぬか及び豆由来ペプチドを含有し、枯草菌が増殖して発酵培養をすることが できる培地であればよい。上記培地の種類及び組成には特に限定はない。上記培 地は、通常、液体培地であるが、固形培地であってもよい。また、上記培地の pH (特 に発酵 B寺) ίま、通常 5· 5〜8· 5、好ましく ίま 6· 0〜8· 0、更に好ましく ίま 6· 5〜7· 5 である。また、上記培地には、 pH及び栄養条件等を好ましい範囲に調整するため、 グノレコース等の糖類、プロテアーゼ等の酵素、精製水等の水等を添加することができ る。 [0042] The above-mentioned "fermented product" is usually obtained by a fermentation process in which Bacillus subtilis is inoculated and fermented in a medium containing rice bran and legume-derived peptides. The “medium” in the “fermentation step” may be any medium that contains rice bran and a bean-derived peptide and that allows Bacillus subtilis to grow and perform fermentation culture. There is no limitation in particular in the kind and composition of the said culture medium. The medium is usually a liquid medium, but may be a solid medium. Further, the pH of the above medium (especially fermentation B temple) is usually 5 · 5 to 8 · 5, preferably ま or 6 · 0 to 8 · 0, and more preferably ま or 6 · 5 to 7 · 5. In addition, in order to adjust pH and nutritional conditions to a preferable range, saccharides such as gnolecose, enzymes such as protease, water such as purified water, and the like can be added to the medium.
[0043] 上記発酵の際の培養温度は、発酵が行われる限り特に制限はない。該培養温度は 、通常 15〜50°C、好ましく ίま 20〜45°C、更に好ましく ίま 30〜45°C、より好ましく ίま 3 5〜43°Cである。発酵培養は通常、通気攪拌を行うことにより行われる。  [0043] The culture temperature during the fermentation is not particularly limited as long as the fermentation is performed. The culture temperature is usually 15 to 50 ° C, preferably 20 to 45 ° C, more preferably 30 to 45 ° C, more preferably 35 to 43 ° C. Fermentation culture is usually performed by aeration and agitation.
[0044] 上記発酵工程により得られる上記発酵物の形態も特に限定されない。上記発酵物 の形態は、本発明の発酵物組成物で説明した内容が適用される。  [0044] The form of the fermented product obtained by the fermentation process is not particularly limited. The contents described in the fermented product composition of the present invention are applied to the fermented product.
[0045] 上記「混合工程」におレ、て、上記発酵物と上記ペプチド及びビタミン A類の少なくと も 1種とを混合する方法には特に限定はない。発酵物とペプチドとは各々の形態、及 びそれぞれの質量割合等によってホモミキサー等の混合器などの適宜の装置を用い て混合することができる。また、混合時の温度も特に限定されず、発酵物及びべプチ ドのそれぞれの種類等によって設定することが好ましい。発酵物とペプチドとは、 5〜 20°Cの範囲で必要に応じて冷却しながら混合することができ、 35〜85°Cの範囲で 必要に応じて加熱しながら混合することもできる。 [0045] There is no particular limitation on the method of mixing the fermented product with at least one of the peptide and vitamin A in the "mixing step". The fermented product and the peptide can be mixed using an appropriate apparatus such as a mixer such as a homomixer depending on the form and the mass ratio of each. Further, the temperature at the time of mixing is not particularly limited, and is preferably set according to the type of fermented product and peptide. Fermented products and peptides are 5 ~ It can be mixed while cooling if necessary in the range of 20 ° C, and can be mixed while heating if necessary in the range of 35 to 85 ° C.
[0046] 本発明の製造方法は、更に他の工程を備えていてもよい。該他の工程としては、例 えば、上記発酵物を精製処理する工程等が挙げられる。発酵工程により得られた発 酵物はそのままペプチドと混合してもよぐ又は該発酵物を精製処理し、その後、ぺ プチドと混合してもよい。この精製処理の方法は特に限定されない。例えば、発酵液 を圧搾し、ろ過することにより、上記発酵物を精製することができる。また、発酵液を圧 搾し、ろ過し、次いで、活性炭等による脱臭、脱色処理、及び Z又は沈殿物の除去 処理をし、その後、再度ろ過することにより、上記発酵物を精製することもできる。  [0046] The production method of the present invention may further include other steps. As this other process, the process etc. which refine | purify the said fermented material are mentioned, for example. The fermented product obtained by the fermentation process may be mixed with the peptide as it is, or the fermented product may be purified and then mixed with the peptide. The method for this purification treatment is not particularly limited. For example, the fermented product can be purified by pressing and filtering the fermentation broth. In addition, the fermentation broth can be purified by squeezing and filtering the fermented liquor, followed by deodorization with activated charcoal and the like, decoloration treatment, and Z or sediment removal treatment, and then filtering again. .
[0047] 上記発酵物組成物を製剤化して化粧品組成物及び細胞賦活用皮膚外用剤組成 物を得る工程の内容は、化粧品組成物及び細胞賦活用皮膚外用剤組成物を得られ る限り特に限定はない。通常は、上記発酵物組成物と化粧品組成物及び細胞賦活 用皮膚外用剤組成物を構成する他の原料とを混合し、錠剤又は液剤等に製剤化す ることにより、化粧品組成物及び細胞賦活用皮膚外用剤組成物を得ることができる。 勿論、上記発酵物組成物をそのまま、錠剤又は液剤等に製剤化することにより、化粧 品組成物及び細胞賦活用皮膚外用剤組成物とすることもできる。  [0047] The contents of the step of obtaining the cosmetic composition and the cell-applied skin external preparation composition by formulating the fermented product composition are particularly limited as long as the cosmetic composition and the cell-applied skin external preparation composition can be obtained. There is no. Usually, the fermented composition, the cosmetic composition, and other ingredients constituting the cell activation skin external preparation composition are mixed and formulated into a tablet or liquid preparation, so that the cosmetic composition and the cell utilization are obtained. A skin external preparation composition can be obtained. Of course, the above fermented product composition can be directly formulated into a tablet or liquid preparation to make a cosmetic composition and a cell-utilized skin external preparation composition.
実施例  Example
[0048] 以下、本発明を実施例により具体的に説明する。  Hereinafter, the present invention will be specifically described with reference to examples.
[1]発酵物組成物の製造  [1] Manufacture of fermented product composition
米ぬか 3kg、大豆ペプチド 0. 4kg、グルコース 0.5kg、アルカリ性プロテアーゼ 0. 0 lkg及び精製水 50kgを混合し、培地を調製した。その後、培地の pHを 6. 0〜8. 0 に調整し、次いで、納豆菌を接種し、 37°Cで 38時間培養して発酵を行った。その後 、発酵液を圧搾及びろ過し、次いで、活性炭により脱色、脱臭した。その後、再度発 酵液をろ過して精製することにより、発酵物を製造した。  Rice bran 3 kg, soybean peptide 0.4 kg, glucose 0.5 kg, alkaline protease 0.0 lkg and purified water 50 kg were mixed to prepare a medium. Thereafter, the pH of the medium was adjusted to 6.0 to 8.0, then inoculated with Bacillus natto, and cultured at 37 ° C for 38 hours for fermentation. Thereafter, the fermentation broth was squeezed and filtered, and then decolorized and deodorized with activated carbon. Then, the fermented product was manufactured by filtering and refine | purifying a fermentation liquid again.
[0049] [2]シルクフイブ口インを含む発酵物組成物の評価  [0049] [2] Evaluation of fermented composition containing silk hive mouth-in
上記 [1]で製造した発酵物、ビタミン C (和光純薬工業社製)、及びシノレタフイブロイ ン (オードレマン社製、商品名「フイブ口インシート」)を、それぞれ固形分濃度で 2% ( 質量/体積)となるように、緩衝液 (PBS)に溶解した。次いで、該溶液を 0. 22 /i m のフィルタによりろ過した。その後、各成分が表 1及び表 2に記載の濃度となるように 該溶液を希釈して混合することにより、実験例 2〜: 15の試料溶液を調製した。また、 実験例 1は、試料溶液として、上記緩衝液(PBS)を使用した。 The fermented product manufactured in [1] above, vitamin C (manufactured by Wako Pure Chemical Industries, Ltd.), and synoleta fibroin (manufactured by Audleman Co., Ltd., trade name “Five Mouth In Sheet”) are each 2% in terms of solid content. (Mass / volume) was dissolved in a buffer solution (PBS). The solution was then added to 0.22 / im It filtered with the filter of. Then, the sample solutions of Experimental Examples 2 to 15 were prepared by diluting and mixing the solutions so that each component had a concentration described in Table 1 and Table 2. In Experimental Example 1, the buffer solution (PBS) was used as a sample solution.
[0050] 2つの 96穴ゥエルプレート(表中では「P1」及び「P2」という。)のそれぞれに、 1ゥェ ノレ当たり 5000個のヒト皮膚繊維芽細胞を撒布した。次いで、 5%FBS添加 MEM培 地で 3日間培養した。 5%FBS添加 MEM培地に対して実験例:!〜 15の試料を添加 して試料添加培地を調製した。該試料添加培地における実験例:!〜 15の試料溶液 の濃度は 1 % (質量/体積、但し、上記 PBSの質量を除く。)である(従って、培地に おける発酵物組成物中の各成分の最終濃度は試料溶液中の濃度の 1 Z 100である 。)。そして、ゥエル中の上記 5%FBS添加 MEM培地を上記試料添加培地に交換し 、更に 3日間培養した。 [0050] 5000 human skin fibroblasts per 1 well were distributed in each of two 96-well well plates (referred to as “P1” and “P2” in the table). Subsequently, the cells were cultured for 3 days in a MEM medium supplemented with 5% FBS. Experimental example:! ~ 15 samples were added to MEM medium supplemented with 5% FBS to prepare sample-added medium. Experimental example in the sample-added medium: The concentration of the sample solution of! To 15 is 1% (mass / volume, excluding the mass of the PBS) (therefore, each component in the fermented composition in the medium) The final concentration of is 1 Z 100 of the concentration in the sample solution.) Then, the 5% FBS-added MEM medium in the well was replaced with the sample-added medium, and further cultured for 3 days.
[0051] 次いで、「コラーゲンスティンキット」(コラーゲン技術研究会製)を用いて、キットに 添付されたマニュアルに従ってコラーゲン合成量( / g)を測定した。プレート 1 (P1) 及びプレート 2 (P2)におけるコラーゲン合成量の平均値を表 1及び表 2に示す。また 、実験例 1のコラーゲン合成量を 1として、実験例 2〜8のコラーゲン合成量の相対値 を求めた。同様に、実験例 9のコラーゲン合成量を 1として、実験例 10〜: 15のコラー ゲン合成量の相対値を求めた。この結果を表 1及び表 2に併記する。尚、表 1及び表 2において、「VC」はビタミン Cを意味し、「SF」はシルクフイブ口インを意味する。  [0051] Next, using a "collagen stin kit" (manufactured by Collagen Technology Research Group), the amount of collagen synthesis (/ g) was measured according to the manual attached to the kit. Tables 1 and 2 show the average values of collagen synthesis in Plate 1 (P1) and Plate 2 (P2). Further, assuming that the collagen synthesis amount of Experimental Example 1 was 1, relative values of the collagen synthesis amounts of Experimental Examples 2 to 8 were obtained. Similarly, assuming that the collagen synthesis amount of Experimental Example 9 is 1, the relative value of the collagen synthesis amount of Experimental Examples 10 to 15 was determined. The results are also shown in Tables 1 and 2. In Tables 1 and 2, “VC” means vitamin C, and “SF” means silk fiber mouth-in.
[0052] [表 1] [0052] [Table 1]
コラ'一ゲン合成量 Kola's single synthesis amount
5式 相対値 平均値 )  (5 formulas Relative value Average value)
P 1 P2 P 1 P2 P 1 P2 P 1 P2
1 PBS (-) 100% 1. 00 1. 00 1. 21 1. 301 PBS (-) 100% 1. 00 1. 00 1. 21 1. 30
2 VC 1% 1. 07 1. 18 1. 9 1. 52 実 3 発酵物 1% 1. 22 1. 05 1. 47 1. 36 2 VC 1% 1. 07 1. 18 1. 9 1. 52 Actual 3 Fermented product 1% 1. 22 1. 05 1. 47 1. 36
4 SF 1% 1. 27 1. 18 1. 53 1. 52 4 SF 1% 1. 27 1. 18 1. 53 1. 52
5 発酵物 0. 5% + SF 0. 5% 1. 49 1. 44 1. 80 1. 87 例 6 発酵物 1. 0% + SF 1. 0% 1. 75 1. 77 2. 1 1 2. 29 5 Fermented product 0.5% + SF 0.5% 1. 49 1. 44 1. 80 1. 87 Example 6 Fermented product 1. 0% + SF 1. 0% 1. 75 1. 77 2. 1 1 2 . 29
7 発酵物 1. 8% + SF 0. 2% 1. 40 1. 26 1. 68 1. 64 7 Fermented product 1. 8% + SF 0. 2% 1. 40 1. 26 1. 68 1. 64
8 発酵物 0. 2% + SF 1. 8% 1. 75 1. 54 2. 1 1 1. 99 [表 2] 8 Fermented product 0.2% + SF 1. 8% 1. 75 1. 54 2. 1 1 1. 99 [Table 2]
2 2
Figure imgf000016_0001
Figure imgf000016_0001
表 1及び表 2より、シルクフイブ口インと発酵物とを併用している実験例 5〜8及び 13 〜15では、発酵物のみを用いている実験例 3及び 11並びにシルクフイブ口インのみ を用いてレ、る実験例 4及び 12に比べてコラーゲン合成作用に優れてレ、ることが分か る。 [0055] [3]他のシルク原料由来のペプチドを含む発酵物組成物の評価 From Tables 1 and 2, in Experimental Examples 5 to 8 and 13 to 15 that use both silk-five mouth-in and fermented products, only Experimental Examples 3 and 11 that use only fermented products and Silk-five mouth-in are used. It can be seen that the collagen synthesizing action is superior to those of Experimental Examples 4 and 12. [0055] [3] Evaluation of fermented product compositions containing peptides derived from other silk raw materials
上記 [1]で製造した発酵物、ビタミン C (和光純薬工業社製)、シノレタフイブ口イン、 及び下記シルクペプチド (a)及び (b)を、それぞれ固形分濃度で 2% (質量/体積) となるように、緩衝液(PBS)に溶解した。次いで、該溶液を 0. 22 z mのフイノレタによ りろ過した。その後、各成分が表 3〜表 5に記載の濃度となるように該溶液を希釈して 混合することにより、実験例 17〜: 19、 24〜28、及び 33〜35の試料溶液を調製した 。また、実験例 17〜: 19、 24〜28、及び 33〜35の試料溶液を体積で等量混合する ことにより、実験例 20〜22、 29〜31、及び 36の試料溶液を調製した。尚、実験例 1 6、 23及び 32では、試料溶液として、上記緩衝液(PBS)を使用した。  Fermented product manufactured in [1] above, vitamin C (manufactured by Wako Pure Chemical Industries, Ltd.), Shinoleta five mouth-in, and the following silk peptides (a) and (b) are each 2% (mass / volume) in solid content concentration So that it was dissolved in a buffer solution (PBS). The solution was then filtered through a 0.22 zm fineletter. Thereafter, the sample solutions of Experimental Examples 17-: 19, 24-28, and 33-35 were prepared by diluting and mixing the solutions so that each component had a concentration described in Tables 3 to 5. . Moreover, the sample solutions of Experimental Examples 20-22, 29-31, and 36 were prepared by mixing the sample solutions of Experimental Examples 17-: 19, 24-28, and 33-35 in equal amounts by volume. In Experimental Examples 16, 23 and 32, the buffer solution (PBS) was used as a sample solution.
[0056] ビタミン C及びシルクフイブ口インは、上記 [2]で用いたものと同じである。また、シル クペプチド(a)及び(b)としては下記のものを用いた。尚、シルクペプチド(a)及び(b) はいずれも液体であり、固形分濃度としての終濃度が 1% (質量 Z体積)となるように 緩衝液により希釈して用いた。  [0056] Vitamin C and silk fiber mouth-in are the same as those used in [2] above. In addition, the following were used as silk peptides (a) and (b). Silk peptides (a) and (b) were both liquids, and were diluted with a buffer solution so that the final concentration as a solid content concentration was 1% (mass Z volume).
シルクペプチド(a);コスモ食品社製、商品名「シルクペプチド M— 500」 シノレクペプチド(b);コスモ食品社製、商品名「シノレクペプチド M— 500 # 60」 Silk peptide (a); Cosmo Foods, trade name "Silk Peptide M-500" Synolec peptide (b); Cosmo Foods, trade name "Sinolec peptide M-500 # 60"
[0057] 上記 [2]と同じ方法により、実験例 16〜36のコラーゲン合成量 g)を測定した。 [0057] Collagen synthesis amount g) of Experimental Examples 16 to 36 was measured by the same method as in [2] above.
プレート 1 (P1)及びプレート 2 (P2)におけるコラーゲン合成量の平均値を表 3〜表 5 に示す。また、実験例 16、 23及び 32の各コラーゲン合成量を 1として、他の実験例 のコラーゲン合成量の相対値を求めた。この結果を表 3〜表 5に併記する。尚、表 3 〜表 5において、「VC」はビタミン Cを意味し、「SF」はシルクフイブ口インを意味し、「 SPJはシルクペプチドを意味する。  Tables 3 to 5 show the average values of collagen synthesis in Plate 1 (P1) and Plate 2 (P2). Further, assuming that each collagen synthesis amount in Experimental Examples 16, 23 and 32 was 1, the relative value of the collagen synthesis amount in other experimental examples was determined. The results are also shown in Tables 3-5. In Tables 3 to 5, “VC” means vitamin C, “SF” means silk five mouth in, and “SPJ means silk peptide”.
[0058] [表 3] 表 3 [0058] [Table 3] Table 3
Figure imgf000018_0001
Figure imgf000018_0001
[0059] [表 4]  [0059] [Table 4]
表 4  Table 4
Figure imgf000018_0002
Figure imgf000018_0002
[0060] [表 5] 表 5 [0060] [Table 5] Table 5
Figure imgf000019_0001
Figure imgf000019_0001
[0061] 表 3〜5の結果によれば、シノレタフイブ口インと発酵物とを併用している実験例 22、 2 9及び 36では、発酵物のみを用いている実験例 18、 25及び 34、並びにシルクフイブ 口インのみを用いている実験例 19、 26及び 35に比べて前記と同様により優れたコラ 一ゲン合成作用を有している。更に、シルクペプチドと発酵物とを併用している実験 例 30及び 31も、シノレタフイブ口インの場合と同様に、より優れたコラーゲン合成作用 を有していることが分かる。尚、実験例 17、 24及び 33より、ビタミン Cもコラーゲン合 成作用を有していることが分かる。しかし、発酵物とビタミン Cとを併用した実験例 20 及びビタミン Cとシルクフイブ口インとを併用した実験例 21では、併用による相乗効果 はみられないか、又は極く僅かであることが分かる。従って、発酵物とペプチドとの併 用による相乗効果が大きレ、ことが分かる。  [0061] According to the results of Tables 3 to 5, in Experimental Examples 22, 29, and 36 using the sinoletafive mouth-in and the fermented product, Experimental Examples 18, 25, and 34 using only the fermented product, In addition, as compared with Experimental Examples 19, 26 and 35 using only silk fiber mouth-in, it has a superior collagen synthesizing action as described above. Furthermore, it can be seen that Experimental Examples 30 and 31 in which the silk peptide and the fermented material are used in combination also have a superior collagen synthesizing action as in the case of sinoleta five mouth-in. From Experimental Examples 17, 24 and 33, it can be seen that vitamin C also has a collagen synthesizing action. However, in Experimental Example 20 in which fermented product and vitamin C are used in combination and in Experimental Example 21 in which vitamin C and silk fiber mouth-in are used in combination, the synergistic effect of the combined use is not observed, or is found to be very slight. Therefore, it can be seen that the synergistic effect of the combined use of the fermented product and the peptide is large.
[0062] [4]大豆ペプチドを含む発酵物,組成物の評価  [0062] [4] Evaluation of fermented product and composition containing soy peptide
上記 [1]で製造した発酵物、ビタミン C (和光純薬工業社製)、シノレタフイブ口イン、 及び下記大豆ペプチド (a)〜(c)を、それぞれ固形分濃度で 2% (質量/体積)とな るように、緩衝液(PBS)に溶解した。次いで、該溶液を 0. 22 /i mのフィルタによりろ 過した。その後、各成分が表 6及び表 7に記載の濃度となるように該溶液を希釈して 混合することにより、実験例 38〜43及び 49〜54の試料溶液を調製した。また、実験 例 38〜43及び 49〜54の試料溶液を体積で等量混合することにより、実験例 44〜4 7及び 55〜56の試料溶液を調製した。尚、実験例 37及び 48では、試料溶液として 、上記緩衝液(PBS)を使用した。 Fermented product manufactured in [1] above, Vitamin C (manufactured by Wako Pure Chemical Industries, Ltd.), Synoletafibu mouth-in, and the following soybean peptides (a) to (c), each with a solid content concentration of 2% (mass / volume) The sample was dissolved in a buffer solution (PBS). The solution was then filtered through a 0.22 / im filter. Thereafter, the solutions were diluted and mixed so that each component had a concentration described in Table 6 and Table 7, thereby preparing sample solutions of Experimental Examples 38 to 43 and 49 to 54. Moreover, the sample solutions of Experimental Examples 44 to 47 and 55 to 56 were prepared by mixing equal amounts of the sample solutions of Experimental Examples 38 to 43 and 49 to 54 by volume. In Experimental Examples 37 and 48, the sample solution was The buffer solution (PBS) was used.
[0063] ビタミン C及びシルクフイブ口インは、上記 [2]で用いたものと同じである。また、大豆 ペプチド(a)〜(c)としては下記のものを用いた。尚、大豆ペプチド(a)、(b)及び(c) はいずれも液体であり、固形分濃度としての終濃度が 1% (質量 Z体積)となるように 緩衝液により希釈して用いた。  [0063] Vitamin C and silk fiber mouth-in are the same as those used in [2] above. The following were used as soybean peptides (a) to (c). The soybean peptides (a), (b), and (c) were all liquids, and were used after being diluted with a buffer solution so that the final concentration as a solid content concentration was 1% (mass Z volume).
大豆ペプチド(a);不二製油社製、商品名「ハイ二ユート SMP」  Soy peptide (a): Fuji Oil Co., Ltd.
大豆ペプチド (b);不二製油社製、商品名「ハイ二ユート R」  Soy peptide (b): Fuji Oil Co., Ltd.
大豆ペプチド(c);不二製油社製、商品名「ハイ二ユート DC5」  Soy peptide (c); Fuji Oil Co., Ltd., trade name “Hynyute DC5”
[0064] 上記 [2]と同じ方法により、実験例 37〜47のコラーゲン合成量(μ g)を測定した。  [0064] By the same method as in [2] above, the amount of collagen synthesis (μg) in Experimental Examples 37 to 47 was measured.
プレート 1 (P1)及びプレート 2 (P2)におけるコラーゲン合成量の平均値を表 6に示す 。また、実験例 37のコラーゲン合成量を 1として、他の実験例のコラーゲン合成量の 相対値を求めた。この結果を表 6に併記する。尚、表 6において、「VC」はビタミン Cを 意味し、「SF」はシノレタフイブ口インを意味し、 8? (&)〜((:)」は大豆ぺプチド(&)〜 (c)を意味する。  Table 6 shows the average value of the amount of collagen synthesis in Plate 1 (P1) and Plate 2 (P2). Further, assuming that the amount of collagen synthesis in Experimental Example 37 was 1, the relative value of the amount of collagen synthesis in other Experimental Examples was determined. The results are also shown in Table 6. In Table 6, “VC” means Vitamin C, “SF” means Synoletafibu Mouth Inn, and 8? (&) To ((:) ”are soybean peptides (&) to (c). means.
[0065] [表 6] [0065] [Table 6]
表 6 Table 6
Figure imgf000021_0001
Figure imgf000021_0001
[0066] 2つの 96穴ゥエルプレートのそれぞれに、 1ゥエル当たり 2000個のヒト皮膚繊維芽 細胞を撒布した。次いで、 5%FBS添加 MEM培地で 3日間培養した。その後、無血 清 MEM培地に交換し、更に 1日間培養した。 0. 5%血清添加 MEM培地に対して 実験例 48〜56の試料を添加して試料添加培地を調製した。該試料添加培地にお ける上記実験例 48〜56の試料溶液の濃度は 1% (質量 Z体積、但し、上記 PBSの 質量を除く。)である(従って、培地における発酵物組成物中の各成分の最終濃度は 試料溶液中の濃度の 1/100である。)。そして、ゥエル中の上記無血清 MEM培地 を上記試料添加培地に交換し、更に 4日間培養した。  [0066] Each of the two 96-well plate was distributed with 2000 human skin fibroblasts per well. Subsequently, the cells were cultured for 3 days in a MEM medium supplemented with 5% FBS. Thereafter, the medium was replaced with a serum-free MEM medium and further cultured for 1 day. 0.5% serum-added MEM medium A sample-added medium was prepared by adding the samples of Experimental Examples 48-56. The concentration of the sample solutions of the above Experimental Examples 48 to 56 in the sample-added medium is 1% (mass Z volume, excluding the mass of the PBS). The final concentration of the component is 1/100 of the concentration in the sample solution.) Then, the serum-free MEM medium in the well was replaced with the sample-added medium, and further cultured for 4 days.
[0067] その後、同仁堂「セルカウンティングキット 8」に基づき、 WST— 8テトラゾリゥム塩を 発色基質とし、生細胞内の脱水素酵素により還元されて生成した水溶性ホルマザン を 450nmの波長で測定することにより、吸光度を測定した(生細胞数は当該吸光度 の値に比例する。)。また、実験例 48の生細胞数を 1として、他の実験例の生細胞量 の相対値を算出し、細胞増殖作用を評価した。結果を表 7に併記する。尚、表 7にお いて、「¥〇」はビタミン〇を意味し、「SF」はシルクフイブ口インを意味し、「SBP (a)〜( c)」は大豆ペプチド(a)〜(c)を意味する。また、表 7における細胞増殖率の項の平 均値は、上記吸光度の値の平均値である。 [0067] Then, based on Dojindo “Cell Counting Kit 8”, WST-8 tetrazolium salt was used as a chromogenic substrate, and water-soluble formazan produced by reduction by dehydrogenase in living cells was measured at a wavelength of 450 nm. Then, the absorbance was measured (the number of living cells is proportional to the absorbance value). Further, assuming that the number of living cells in Experimental Example 48 was 1, the relative value of the amount of living cells in other Experimental Examples was calculated, and the cell proliferation action was evaluated. The results are also shown in Table 7. In Table 7, “¥ 0” means vitamin 0, “SF” means silk-five mouth-in, and “SBP (a) to (c)” means soybean peptides (a) to (c). The average value of the cell growth rate term in Table 7 is the average value of the absorbance values.
[0068] [表 7] 表 7 [0068] [Table 7] Table 7
Figure imgf000022_0001
Figure imgf000022_0001
[0069] 表 6より、シルクフイブ口インと発酵物とを併用している実験例 44は、発酵物のみを 用いている実験例 39及びシノレタフイブ口インのみを用いている実験例 40に比べて、 より優れたコラーゲン合成作用を有することが分かる。更に、発酵物と大豆ペプチドと を併用している実験例 45〜47も、シノレタフイブ口インの場合と同様に、より優れたコラ 一ゲン合成作用を有することが分かる。  [0069] From Table 6, Experimental Example 44 using both silk-five mouth-in and fermented product compared to Experimental Example 39 using only fermented product and Experimental Example 40 using only Synoleta-Five mouth-in, It can be seen that it has a better collagen synthesis action. Furthermore, it can be seen that Experimental Examples 45 to 47 in which the fermented product and the soybean peptide are used in combination also have a superior collagen synthesizing action as in the case of Synoletafibu mouth-in.
[0070] 表 7より、発酵物と大豆ペプチド(c)とを併用している実験例 56は、発酵物のみを用 レ、ている実験例 50に比べて細胞増殖作用がより向上していることが分かる。更に、発 酵物とシノレタフイブ口インとを併用した実験例 55も、同様に細胞増殖作用が向上して レ、ることが分かる。  [0070] From Table 7, Experimental Example 56 using both the fermented product and soybean peptide (c) has a more improved cell proliferation effect than Experimental Example 50 using only the fermented product. I understand that. Furthermore, it can be seen that Experimental Example 55 using both the fermented product and the sinoletafib mouth-in also improves the cell proliferation action.
[0071] [5]ビタミン A類を含む発酵物組成物の評価  [0071] [5] Evaluation of fermented product composition containing vitamin A
上記 [1]で製造した発酵物、ビタミン C (和光純薬工業社製)、及びシクロデキストリ ン包接レチノール(商品名「CAVAMAX W8/Retinol Complex」 シクロケム社 製)を、それぞれ固形分濃度で 2% (質量/体積)となるように、緩衝液 (PBS)に溶解 した。次いで、該溶液を 0. 22 / mのフィルタによりろ過した。その後、各成分が表 8 に記載の濃度となるように該溶液を希釈して混合することにより、実験例 58〜66の試 料溶液を調製した。尚、実験例 57では、試料溶液として、上記緩衝液 (PBS)を使用 した。 Fermented product manufactured in [1] above, vitamin C (manufactured by Wako Pure Chemical Industries, Ltd.), and cyclodextri Inclusion retinol (trade name “CAVAMAX W8 / Retinol Complex” manufactured by Cyclochem) was dissolved in a buffer solution (PBS) so that the solid concentration was 2% (mass / volume). The solution was then filtered through a 0.22 / m filter. Thereafter, the solutions were diluted so that each component had a concentration shown in Table 8 and mixed to prepare sample solutions of Experimental Examples 58 to 66. In Experimental Example 57, the buffer solution (PBS) was used as the sample solution.
[0072] 上記 [2]及び [4]記載の方法と同じ方法により、実験例 57〜66のコラーゲン合成 量( z g)及び細胞増殖率を測定した。その平均値を表 8に示す。また、実験例 57の コラーゲン合成量及び生細胞量を 1として、他の実験例のコラーゲン合成量及び生 細胞量の相対値を求めた。この結果を表 8に併記する。尚、表 8において、「 〇」は ビタミン Cを意味し、「CDR」はシクロデキストリン包接レチノールを意味する。また、表 8における細胞増殖率の項の平均値は、吸光度の値の平均値である。  [0072] The collagen synthesis amount (z g) and cell proliferation rate of Experimental Examples 57 to 66 were measured by the same method as described in [2] and [4] above. The average value is shown in Table 8. Further, assuming that the amount of collagen synthesis and the amount of living cells in Experimental Example 57 was 1, the relative values of the amount of collagen synthesis and the amount of living cells in other Experimental Examples were determined. The results are also shown in Table 8. In Table 8, “◯” means vitamin C, and “CDR” means cyclodextrin inclusion retinol. Moreover, the average value of the term of cell growth rate in Table 8 is the average value of absorbance values.
[0073] [表 8] 表 8  [0073] [Table 8] Table 8
Figure imgf000023_0001
Figure imgf000023_0001
[0074] 表 8より、レチノールと発酵物とを併用している実験例 64〜66は、発酵物のみを用 いている実験例 59及びレチノールのみを用いている実験例 60〜63に比べて、優れ たコラーゲン合成作用及び細胞増殖作用を有することが分かる。 [0074] From Table 8, Experimental Examples 64 to 66 using both retinol and fermented product are compared to Experimental Example 59 using only fermented product and Experimental Examples 60 to 63 using only retinol, Excellent It can be seen that it has a collagen synthesizing action and a cell proliferating action.
[0075] [6]ペプチド及びビタミン A類を含む発酵物組成物の評価  [0075] [6] Evaluation of fermented product composition containing peptide and vitamin A
上記 [1]で製造した発酵物、上記シルクフイブ口イン、上記大豆ペプチド(a)、及び 上記シクロデキストリン包接レチノールを、それぞれ固形分濃度で 2。/0 (質量/体積) となるように、緩衝液(PBS)に溶解した。次いで、該溶液を 0. 22 z mのフイノレタによ りろ過した。その後、各成分が表 9及び表 10に記載の濃度となるように該溶液を希釈 して混合することにより、実験例 68、 69、 71及び 72の試料溶液を調製した。尚、実 験例 67及び 70では、試料溶液として、上記緩衝液(PBS)を使用した。 The fermented product produced in [1] above, the silk fiber mouth-in, the soybean peptide (a), and the cyclodextrin inclusion retinol in solid content concentrations of 2, respectively. It was dissolved in a buffer solution (PBS) so as to be / 0 (mass / volume). The solution was then filtered through a 0.22 zm fineletter. Thereafter, the sample solutions of Experimental Examples 68, 69, 71, and 72 were prepared by diluting and mixing the solutions so that each component had a concentration described in Table 9 and Table 10. In Experimental Examples 67 and 70, the buffer solution (PBS) was used as the sample solution.
[0076] 上記 [2]及び [4]と同じ方法により、実験例 67〜72のコラーゲン合成量( x g)及び 細胞増殖率を測定した。その平均値を表 9及び表 10に示す。また、実験例 67及び 7 0のコラーゲン合成量及び生細胞量を 1として、他の実験例のコラーゲン合成量及び 生細胞量の相対値を求めた。この結果を表 9及び表 10に併記する。尚、表 9及び表 10において、「SF」はシルクフイブ口インを意味し、「SBP」は大豆ペプチドを意味し、 「CDR」はシクロデキストリン包接レチノールを意味する。また、表 9及び表 10におけ る細胞増殖率の項の平均値は、吸光度の値の平均値である。  [0076] By the same method as in [2] and [4] above, the amount of collagen synthesis (x g) and cell proliferation rate of Experimental Examples 67 to 72 were measured. The average values are shown in Table 9 and Table 10. Further, with the amount of collagen synthesis and the amount of living cells in Experimental Examples 67 and 70 as 1, the relative values of the amount of collagen synthesis and the amount of living cells in other Experimental Examples were determined. The results are also shown in Table 9 and Table 10. In Tables 9 and 10, “SF” means silk-five mouth-in, “SBP” means soybean peptide, and “CDR” means cyclodextrin inclusion retinol. In Table 9 and Table 10, the average value of the term of cell proliferation rate is the average value of absorbance.
[0077] [表 9] [0077] [Table 9]
Figure imgf000025_0001
Figure imgf000025_0001
表 9
Figure imgf000025_0002
Table 9
Figure imgf000025_0002
Yes
Figure imgf000026_0001
Figure imgf000026_0001
[0079] 表 10より、レチノール及びペプチドと発酵物とを併用している実験例 69及び 72は、 優れたコラーゲン合成作用及び細胞増殖作用を有することが分かる。 [0079] From Table 10, Experimental Examples 69 and 72 using retinol and a peptide together with a fermented product are as follows: It can be seen that it has excellent collagen synthesis action and cell proliferation action.
[0080] 尚、本発明は、上記具体的実施例に限定されない。本発明は、 目的、用途に応じ て本発明の範囲内で種々変更することができる。  [0080] The present invention is not limited to the specific examples described above. The present invention can be variously modified within the scope of the present invention depending on the purpose and application.
産業上の利用可能性  Industrial applicability
[0081] 本発明の発酵物組成物は、安全性に優れ、コラーゲン合成作用等を有する。本発 明の発酵物組成物は、皮膚外用剤等の各種の化粧品並びに健康食品及び機能性 食品等の各種の飲食物等に配合して用いることができる。即ち、本発明は、化粧品 及び飲食物等の分野において利用することができる。 [0081] The fermented product composition of the present invention is excellent in safety and has a collagen synthesis action and the like. The fermented product composition of the present invention can be used by blending it with various cosmetics such as external preparations for skin and various foods such as health foods and functional foods. That is, the present invention can be used in the fields of cosmetics and foods and drinks.

Claims

請求の範囲 The scope of the claims
[1] 米ぬ力、と豆類由来ペプチドとを枯草菌により発酵させて得られる発酵物と、ぺプチ ド及びビタミン A類の少なくとも 1種と、を含有することを特徴とする発酵物組成物。  [1] A fermented product composition comprising a fermented product obtained by fermenting rice bran strength and a bean-derived peptide with Bacillus subtilis, and at least one of a peptide and vitamin A. .
[2] 上記ペプチドは、大豆タンパク質が加水分解されたペプチド及びシルクフイブロイ ンの少なくとも 1種である請求項 1記載の発酵物組成物。 [2] The fermented product composition according to claim 1, wherein the peptide is at least one of a peptide obtained by hydrolyzing soy protein and silk fibroin.
[3] 請求項 1記載の発酵物組成物を含有することを特徴とする化粧品組成物。 [3] A cosmetic composition comprising the fermented product composition according to claim 1.
[4] 米ぬ力と豆類由来ペプチドとを枯草菌により発酵させて得られる発酵物とペプチド 及びビタミン A類の少なくとも 1種とを混合する混合工程を備えることを特徴とする発 酵物組成物の製造方法。 [4] A fermented product composition comprising a mixing step of mixing a fermented product obtained by fermenting rice bran and bean-derived peptides with Bacillus subtilis and at least one of peptides and vitamin A. Production method.
[5] 米ぬ力と豆類由来ペプチドとを枯草菌により発酵させて得られる発酵物とペプチド 及びビタミン A類の少なくとも 1種とを混合する混合工程と、 [5] a mixing step of mixing a fermented product obtained by fermenting rice bran and bean-derived peptides with Bacillus subtilis and at least one of peptides and vitamins A;
該混合工程において得られる発酵物組成物を製剤化して化粧品組成物を得るェ 程と、を備えることを特徴とする化粧品組成物の製造方法。  And a step of formulating the fermented product composition obtained in the mixing step to obtain a cosmetic composition.
PCT/JP2007/059398 2006-05-02 2007-05-02 Fermented product composition, cosmetic composition and method of producing the same WO2007129674A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2007800157909A CN101431980B (en) 2006-05-02 2007-05-02 Fermented product composition, cosmetic composition and method of producing the same
JP2008514485A JP4945556B2 (en) 2006-05-02 2007-05-02 Cell application skin external preparation composition
KR1020087026036A KR101397976B1 (en) 2006-05-02 2007-05-02 Skin external preparation composition for cell activation and method of producing the same
HK09108313.4A HK1130182A1 (en) 2006-05-02 2009-09-10 Fermented product composition, cosmetic composition and method of producing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-128692 2006-05-02
JP2006128692 2006-05-02

Publications (1)

Publication Number Publication Date
WO2007129674A1 true WO2007129674A1 (en) 2007-11-15

Family

ID=38667782

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/059398 WO2007129674A1 (en) 2006-05-02 2007-05-02 Fermented product composition, cosmetic composition and method of producing the same

Country Status (5)

Country Link
JP (2) JP4945556B2 (en)
KR (1) KR101397976B1 (en)
CN (2) CN101431980B (en)
HK (1) HK1130182A1 (en)
WO (1) WO2007129674A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010162006A (en) * 2009-01-19 2010-07-29 Akita Univ Method for producing rice bran leachate from which rice bran smell is eliminated, rice bran leachate from which rice bran smell is eliminated, and method for producing gamma-aminobutyric acid
JP2015086207A (en) * 2013-11-01 2015-05-07 株式会社東洋発酵 Oral composition for beauty and health

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130058107A (en) * 2011-11-25 2013-06-04 (주)아모레퍼시픽 Isolation and preparation of small peptides from soybean and its cosmetic composition
CN102846537B (en) * 2012-10-18 2014-01-29 天津市可美国际贸易有限公司 Preparation method of skin care essence stoste
CN106466291B (en) * 2015-08-19 2019-06-07 德州昂立达生物技术有限公司 A kind of still cleaning products and preparation method thereof containing fermented grain object
CN105596286A (en) * 2016-01-25 2016-05-25 广州保税区雅兰国际化妆品有限公司 Yeast skin-whitening cosmetic composition and preparation method thereof
CN110484569A (en) * 2019-09-18 2019-11-22 上海应用技术大学 A kind of meter of source fermentation material and the preparation method and application thereof
CN112022792B (en) * 2020-09-27 2022-12-09 黑龙江省中医药科学院 Preparation method of edible traditional Chinese medicine hair dye with homology of medicine and food

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08104647A (en) * 1994-10-06 1996-04-23 Mikimoto Pharmaceut Co Ltd Production of raw material for external preparation for skin and external preparation for skin comprising the same raw material as active ingredient
WO2002080862A1 (en) * 2001-04-06 2002-10-17 Toyo Hakko Co., Ltd. Cosmetic materials and process for producing the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3417419B2 (en) * 1992-07-13 2003-06-16 株式会社資生堂 External preparation for skin
JPH10234301A (en) * 1997-02-27 1998-09-08 Meiji Seika Kaisha Ltd Green tea beverage
DE19713092A1 (en) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Complexes of gamma-cyclodextrin and retinol or retinol derivatives, as well as processes for their preparation and their use
JP4755325B2 (en) * 1997-11-04 2011-08-24 一丸ファルコス株式会社 Bioactive composition derived from silk protein hydrolyzate
JP2000327538A (en) * 1999-05-24 2000-11-28 Toyo Hakko:Kk Agent composition for hair treatment
JP2001000140A (en) * 1999-06-22 2001-01-09 Bizen Kasei Kk Composition for removing active oxygen, and its production
JP2001120222A (en) * 1999-10-28 2001-05-08 Bizen Kasei Kk Composition for suppressing formation of peroxy lipids and production therefor
AU2003281532A1 (en) * 2002-07-23 2004-02-09 Fuji Oil Company, Limited Antioxidant and process for producing the same
JP2005080655A (en) * 2003-09-10 2005-03-31 Suetsuna Yoko New composition containing isoflavone and activated oxygen inhibitor
JP4387760B2 (en) * 2003-10-24 2009-12-24 株式会社ラティアクリエイツ Antioxidant composition
JP2005143480A (en) * 2003-11-17 2005-06-09 Hasegawa Hidetoshi Method for producing industrial waste such as rice bran, soybean-curd refuse, beer lees and the like
JP2006213688A (en) * 2005-02-07 2006-08-17 Toshio Oshiro Nk(natural killer) activity enhancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08104647A (en) * 1994-10-06 1996-04-23 Mikimoto Pharmaceut Co Ltd Production of raw material for external preparation for skin and external preparation for skin comprising the same raw material as active ingredient
WO2002080862A1 (en) * 2001-04-06 2002-10-17 Toyo Hakko Co., Ltd. Cosmetic materials and process for producing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUME H. ET AL.: "Shinki Shokubutsu Yurai Placenta-yo Genryo ni yoru Hada no Shiwa.Hari Kaizen ni tsuite", FRAGRANCE JOURNAL, 15 September 2005 (2005-09-15), pages 75 - 80, XP003016929 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010162006A (en) * 2009-01-19 2010-07-29 Akita Univ Method for producing rice bran leachate from which rice bran smell is eliminated, rice bran leachate from which rice bran smell is eliminated, and method for producing gamma-aminobutyric acid
JP2015086207A (en) * 2013-11-01 2015-05-07 株式会社東洋発酵 Oral composition for beauty and health

Also Published As

Publication number Publication date
JPWO2007129674A1 (en) 2009-09-17
CN101431980B (en) 2012-08-01
CN101431980A (en) 2009-05-13
CN102225045A (en) 2011-10-26
KR101397976B1 (en) 2014-05-27
JP4945556B2 (en) 2012-06-06
JP2011173921A (en) 2011-09-08
JP4945692B2 (en) 2012-06-06
HK1130182A1 (en) 2009-12-24
CN102225045B (en) 2013-01-02
KR20090007726A (en) 2009-01-20

Similar Documents

Publication Publication Date Title
JP4945692B2 (en) Cell-utilized skin external preparation composition and method for producing the same
JP5018171B2 (en) Plant-derived activator and extracellular matrix production promoter
WO2011036786A1 (en) Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient
JPWO2007148739A1 (en) Plant-derived cell activator, anti-aging agent, and extracellular matrix production promoter
JPWO2007148737A1 (en) Method for preparing plant extract, plant extract and use thereof
JP2004250372A (en) Skin aging inhibitor/improver and/or rough skin inhibitor/improver kit
JP2023091082A (en) Antipollution agent and topical skin composition
JPWO2020054204A1 (en) Antioxidant
JP2003063925A (en) Skin care preparation
JP3625501B2 (en) Method for producing raw material for skin-applied skin and cell-applied skin external agent
JP2000191494A (en) Composition for beauty culture and health
JP2008105984A (en) Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink
JPH049316A (en) Whitening cosmetic
WO2015052849A1 (en) Novel derivative having collagen-producing activity, and method for producing same
JP2002284632A (en) Extinction substance for superoxide anion extracted from sake lees as effective component
JP2011195537A (en) Antioxidant, whitening agent, anti-aging agent, hair tonic, humectant, skin care preparation and functional oral composition
KR101951646B1 (en) A cosmetic composition comprising marinobacter-fermented spirulina extract for antioxydant and skin winkle improvement
JP5578160B2 (en) Plant-derived activator and extracellular matrix production promoter
CN1747962A (en) Compound, process for producing the same and use thereof
TWI393780B (en) A fermentation composition, a cosmetic composition, and the like
JP3706591B2 (en) Skin preparation
JPH06343479A (en) Thickening agent and its use
JP7476517B2 (en) Anti-glycation agents
KR102473157B1 (en) Nypa fruticans fruit fermented product applicable as halal cosmetic and cosmetic composition containing the same
JP7015775B2 (en) Polyphenol derivative exhibiting gene repair action

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07742833

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008514485

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020087026036

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200780015790.9

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07742833

Country of ref document: EP

Kind code of ref document: A1